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Abstract 
 The impact of the molecular electrostatic potential values (MEPs) in halogen and 
hydrogen bond interactions were explored using two acceptors with multiple acceptor sites with 
twelve hydrogen-bond donors, five halogen bond donors and four mixed halogen and hydrogen 
bond donors. The results suggested if the difference between the two acceptor sites is above 38 
kJ/mol both hydrogen and halogen bond donors prefer the acceptor site with the highest MEP 
value and this selectivity was lost if the difference is below 26 kJ/mol. 
To examine the potential of halogen-bond donors in organocatalysis, a halogen-bond 
donor molecule was synthesized and the catalytic activity was measured using a benchmark 
Ritter type solvolysis reaction. Results suggested the catalytic activity of the halogen-bond donor 
molecule with > 90 % conversion of the product with the use of a stoichiometric amount of the 
catalyst for 96 hrs. Successful use of the control molecules confirm that the catalytic activity is 
an outcome of having halogen-bond donors in the molecule. 
The benefit of using a structural mimic in landscaping the structural outcomes of poorly 
soluble molecules was explored using an anticancer drug erlotinib. A structural mimic was 
synthesized by maintaining all binding sites that are important to design a structural landscape 
and the structural outcomes were analyzed using five FDA approved dicarboxylic acids. The 
results suggested that the structural outcomes of the mimic can be related to the actual drug 
erlotinib. Solubility and thermal behavior analysis of the co-crystals also suggested that with the 
systematic changes of the co-crystallization agent, it is possible to make predictable changes to 
the physical properties. 
To observe the effect of co-crystallization technology in reducing the chemical reactivity 
and sensitivity of an energetic compound dinitrobenzotriazole, a series of co-crystallization 
  
experiments was carried out using fourteen nitrogen and oxygen based acceptors. Four co-
crystals were obtained and the acceptors were identified as supramolecular protecting groups 
which led to successful diminish of chemical instability and decreased impact sensitivity. 
Hygroscopicity and chemical reactivity of tetranitrobisimidazole, a potential RDX 
replacement, was successfully decreased by protecting the acidic N-H protons in the molecule by 
introducing suitable co-formers. Introduction of the N-oxide based acceptors into the system   
enhanced the stability while retaining most of the desirable energetic properties.  
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donor molecule was synthesized and the catalytic activity was measured using a benchmark 
Ritter type solvolysis reaction. Results suggested the catalytic activity of the halogen-bond donor 
molecule with > 90 % conversion of the product with the use of a stoichiometric amount of the 
catalyst for 96 hrs. Successful use of the control molecules confirm that the catalytic activity is 
an outcome of having halogen-bond donors in the molecule. 
The benefit of using a structural mimic in landscaping the structural outcomes of poorly 
soluble molecules was explored using an anticancer drug erlotinib. A structural mimic was 
synthesized by maintaining all binding sites that are important to design a structural landscape 
and the structural outcomes were analyzed using five FDA approved dicarboxylic acids. The 
results suggested that the structural outcomes of the mimic can be related to the actual drug 
erlotinib. Solubility and thermal behavior analysis of the co-crystals also suggested that with the 
systematic changes of the co-crystallization agent, it is possible to make predictable changes to 
the physical properties. 
To observe the effect of co-crystallization technology in reducing the chemical reactivity 
and sensitivity of an energetic compound dinitrobenzotriazole, a series of co-crystallization 
  
experiments was carried out using fourteen nitrogen and oxygen based acceptors. Four co-
crystals were obtained and the acceptors were identified as supramolecular protecting groups 
which led to successful diminish of chemical instability and decreased impact sensitivity. 
Hygroscopicity and chemical reactivity of tetranitrobisimidazole, a potential RDX 
replacement, was successfully decreased by protecting the acidic N-H protons in the molecule by 
introducing suitable co-formers. Introduction of the N-oxide based acceptors into the system   
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Chapter 1 - Introduction 
 1.1 Structure- property relationship of molecules 
A fundamental axiom in science and technology is that “form follows function’ and in 
chemistry this is recognized by that the properties and behavior of molecules follow from their 
structures.1A great deal of information about molecular properties can be obtained by observing 
how atoms in molecules are connected. Nearly seventy years ago pioneering work on structure-
property relationships was carried out by Weiner2 who investigated the properties of 
hydrocarbons and recognized that properties change with molecular bulk and branching.2, 3 Since 
then, structure-property relationships have long guided the discovery and optimization of novel 
materials.4 Studies of structure-property relations in organic molecules can be divided into two 
main categories. Under the first category, bulk properties of materials were analyzed based on 
the presence of strong interactions between molecules. Under the second category, properties 
were analyzed based on the variations on  the molecular structure (Figure 1-1).5 
 
 
  
 
 
 
Figure 1-1 Two main categories of structure-property relation in organic molecules 
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 A study of melting point changes of dicarboxylic acids provides an example of the 
influence of both intermolecular interactions and structural conformation in  the structure-
property relationship.6 Figure 1-2 shows the correlation of the melting points of the even chain 
dicarboxylic acids. With the addition of even number of carbon atoms into the chain, melting 
points were gradually decreased. However as soon as a dicarboxylic acid with an odd number of 
carbon atoms in the chain was introduced this correlation was no longer observed. Even and odd 
chain length dicarboxylic acids have difference in structural conformation which leads to 
different spatial arrangements (Figure 1-3). 
 
Figure 1-2 Correlation of the melting points with the dicarboxylic acid chain length 
 
 
Figure 1-3 Difference of the spatial arrangement of the even chain (top) and odd chain 
(bottom) dicarboxylic acids7 
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This example highlights that the understanding of both molecular and intermolecular 
interactions are important in the design of novel materials with predictable properties. Therefore 
in parallel to the studies of the effect of molecular conformations in altering the structural 
properties, analysis of non-covalent interactions also has been developed as a separate research 
field, and has played a central role in the design of new materials with specific properties.8 
 1.2 Supramolecular chemistry: The chemistry of the non-covalent bond 
Supramolecular chemistry is defined as the ‘chemistry of molecular assemblies and of the 
intermolecular bond’.9 The term was first introduced by  one of  its leading proponents Jean-
Marie Lehn, who won the Nobel prize for his work in the area in 1987.10 More generally 
supramolecular chemistry is ‘chemistry beyond the molecule’ in which it goes beyond the scope 
of using only covalent bonds to make and alter the properties of molecules. In an ideal 
supramolecular process, molecular building blocks are designed to express the specific 
intermolecular interactions to achieve controlled and directional assembly which in turn leads to 
a better understanding of the macroscopic properties of materials (Figure 1-4).  
 
 
 
 
 
 
 
Figure 1-4 Difference between covalent synthesis and supramolecular synthesis 
 
4 
Supramolecular chemistry uses  relatively weak non-covalent interactions like hydrogen bonds, 
halogen bonds, van der Waals forces and π-π interactions in molecular recognition and 
communication8 (Table 1-1).  
Table 1-1 Estimated strengths of molecular interactions11, 12 
  
  
  
  
  
  
  
  
 1.2.1 Crystal engineering: A direction of supramolecular chemistry  
   Crystals are the ultimate examples of supramolecular assemblies. Dunitz13 describes a 
crystal as a supramolecular par-excellence in which millions of molecules are held together by 
non-covalent interactions in a periodic arrangement. A crystal engineer uses non-covalent 
interactions to design ordered supramolecular aggregates whereas a synthetic chemist aims to 
generate molecules through covalent bonds.14 Solid state applications of crystal engineering were 
greatly influenced by the pioneering work done by Schmidt15 who emphasized that the physical 
and chemical properties of crystals are highly dependent on the distribution of the molecular 
components within the crystal lattice. He correlated the idea of solid state reactivity through the 
analysis of 2+2 photodimerization reactions with favorable molecular spacing of the two 
components in the crystal lattice 15 (Figure 1-5). 
  
Type of interaction Strength (kJ/mol) 
Covalent 100-400 
Hydrogen bond 10-65 
π-π 0-50 
Metal-ligand 0-400 
Van der Waal <5 
Halogen bond 5-180 
5 
 
 
 
 
 
 
 
 
 
 
Figure 1-5 Alignment of molecules in a desired orientation to get a photodimerized 
product15  
In another example, Desiraju and co-workers16 showed the importance of the arrangement of 
stilbene based chromophores in a non-centrosymmetric fashion to obtain non-linear optical 
materials17 (Figure 1-6). 
 
 
 
 
 
   
 
Figure 1-6 Primary arrangement of chromophores, noncentrosymmetic arrangement gives 
NLO materials and centrosymmetric arrangements gives non functional materials17 
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Therefore the term crystal engineering can be best defined as the “understanding of 
intermolecular interactions in the context of crystal packing and the utilization of such 
understanding in the design of new solids with desired physical and chemical properties”18 
   1.2.2 Supramolecular synthon 
One of the challenging question in crystal engineering is, given a molecular structure 
compound what is the crystal structure?19 Identification of structural units in a supramolecule 
which can be assembled logically opens a dream path for every crystal engineer.20 Desiraju 
provided a simplification by introducing structural units called supramolecular synthons, which 
are the simplest robust units within the supermolecule which can be assembled by known or 
conceivable intermolecular interactions.21 By dissecting a complex supramolecule into simpler 
structural units, defined by ‘supramolecular retrosynthesis,21,22 it helps to understand the 
molecular arrangement and the interchangeability of synthons in crystal arrangement (Figure1-
7). 
 
 
 
 
 
 
 
 
 
Figure 1-7 Schematic representation of a supramolecular retrosynthesis and covalent 
retrosynthesis 
Supramolecular retrosynthesis 
Covalent retrosynthesis 
7 
Supramolecular synthons carry the key information of the molecular recognition unit and since 
these units are common to many structures, they can be used to arrange molecules in a 
predictable manner.23 Supramolecular synthons are mainly divided into two categories, 
homosynthons and heterosynthons (Figure 1-8). Figure 1-9 illustrates a few examples of robust 
supramolecular synthons which are commonly used in crystal engineering.24 
 
 
 
 
 
 
Figure 1-8 Two main categories of the supramolecular synthon 
 
 
 
 
 
 
 
 
 
 
 
Figure 1-9 Examples of commonly used homo and hetero supramolecular synthons in 
crystal engineering25  
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 1.3 Co-crystallization: A strategy to obtain multicomponent crystals 
Co-crystals are multi component crystals designed through non-covalent interactions. 
They are defined as “solids that are crystalline materials, composed of two or more molecules in 
the same crystal lattice.”26 In co-crystallization molecules are brought together without making 
or breaking covalent bonds, in this process molecules can undergo either homomeric interactions 
(recrystallization) or heteromeric interactions (co-crystallization). Molecules prefer to undergo 
recrystallization over co-cystallization,27 however selecting molecules with complementary 
intermolecular interactions favor the formation of the latter product (Figure 1-10). 
 
 
 
 
  
  
Figure 1-10 Schematic representation of co-crystallization and recrystalization  
 
 1.3.1 Non-covalent interactions: The glue in crystal engineering 
 In co-crystals, molecular components are brought together by several types of 
intermolecular interactions, namely, hydrogen bonds,28 halogen bonds,29 π-π interactions,30 etc.31  
Recognizing the significance of intermolecular interactions on the formation of solid state 
structures has greatly influenced crystal engineering.32 Therefore understanding the properties of 
intermolecular interactions allow for the design of molecules whose functional groups can 
interact non-covalently so that the molecules will pack in a predicted fashion23 (Figure 1-11). 
 
 
Recrystallization Co-crystallization 
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Figure 1-11 Co-crystals based on different of non-covalent interactions 33 
 
 1.3.1.1 Hydrogen bond based co-crystals 
The hydrogen bond is the most studied intermolecular interaction in supramolecular 
chemistry and crystal engineering. The strength and the directionality of the hydrogen bond has 
made it more advantageous in designing functionalized materials in solid state chemistry.34 The 
IUPAC definition of a hydrogen bond is “an attractive interaction between a hydrogen atom from 
a molecule or a molecular fragment X–H in which X is more electronegative than H, and an 
atom or a group of atoms in the same or a different molecule, in which there is evidence of bond 
formation.”35 The field of crystal engineering and solid state chemistry is greatly indebted to the 
influencing work done by Etter and co-workers who started to focus on the control of hydrogen 
bonds in molecular crystallization. Through the analysis of  the Cambridge Structural Database 
of neutral molecules with accessible hydrogen bonding functionalities, Etter and co-workers  
identified possible preferences of hydrogen bonds in terms of selectivity and pattern of molecular 
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aggregation.36 Together with this observation, they proposed a set of guidelines for the 
selectivity of hydrogen bonding, which is known as Etter’s rules.36 The first three general rules 
are highlighted below, 
1. All good proton donors and acceptors are used in hydrogen bonding 
2. If a six membered intramolecular hydrogen bond can form, it will usually do so in preference 
to forming intermolecular hydrogen bonds 
3. The best proton donors and acceptors remaining after intramolecular hydrogen-bond 
formation, form intermolecular hydrogen bonds to one another. 
These guidelines have had a great influence on the development of crystal engineering especially 
the structures built from molecules specifically designed to incorporate multiple hydrogen 
bonding and oriented in arrays to obtain predictable architectures.20  
 1.3.1.2 Halogen- bond based co-crystals 
Halogen bond is another non-covalent interaction which has been added into the 
supramolecular tool box recently.37 They are similar to their more widespread counterpart 
hydrogen bonds.38 Based on the IUPAC recommendations, “a halogen bond occurs when there 
is evidence of a net attractive interaction between an electrophilic region associated with a 
halogen atom in a molecular entity and a nucleophilic region in another, or the same, molecular 
entity”.39 Figure 1-12 illustrates the formation of a halogen bond with different nucleophilic 
species. 
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 Figure 1-12 Schematic diagram showing the formation of a halogen bond with different 
nucleophiles  
 
A covalently bound halogen atom has an anisotropic distribution of electron charge, which 
results in excess negative charge perpendicular to the C-X bond and a depletion of negative 
charge along the C-X bond leading to a positive charge at the tip of the halogen atom, which is 
referred as the ‘σ’ hole.40 Therefore a covalently bound halogen atom has a capacity to interact 
with both nucleophilic and electrophilic species (Figure 1-13). 
 
 
 
 
   
 
Figure 1-13 Anisotropic distribution of positive and negative charges around the halogen 
atom of iodopentafluorobenzene 
 
Following the pioneering work of Metrangolo and Resinati, it is become evident that 
halogen bonds can be used to fine tune the structural outcomes of the self-assembly 37, 41  and 
 D + X  Y  
 D X  Y 
D- C, N, halogen etc. 
X- Cl, Br, I 
Y- N, O, S, Cl, Br, I, Cl-, Br-,I- 
 
δ+  Electrophilic end, halogen bond donor 
δ-       Nucleophilic end, halogen bond acceptor 
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Figure 1-14 shows the use of halogen bonds in the assembly of a linear supramolecular 
arrangement.42 
 
 
 
 
Figure 1-14 Designing supramolecular linear arrangements using halogen bonds42 
  
 1.3.2 Applications of hydrogen and halogen-bond based systems 
Co-crystal technology has been widely used for altering physical properties of 
pharmaceuticals,6, 43, 44 agrochemicals,45energetic materials,46, 47, 48 organic semiconductors,49 
non-linear optics,50 ferroelectric materials51 and charge transfer complexes.52 Furthermore co-
crystallization has been applied in chiral resolution,53 separation and purification processes54 and  
solvent free synthesis processes.55 
 1.3.2.1 Pharmaceuticals 
Pharmaceutical co-crystals have gained widespread attention in the pharmaceutical 
industry with the aim of modifying physiochemical properties of  active pharmaceutical 
ingredients (API).56 Changing the solid form of an API can alter physical properties like 
solubility, thermal stability and bioavailability.43, 57 For example, co-crystals of even chain 
dicarboxylic acids with an anticancer agent hexamethylenebisacetamide showed increase of 
solubility with the use of succinic, adipic and suberic acids as co-formers (Figure 1-15).58 In 
another example, 2-[4-(4-chloro-2-fluorophenoxy)phenyl]pyrimidine-4-carboxamide (used in 
preventing surgical, chronic and neuropathic pain and has extremely low solubility 
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characteristics) and glutaric acid co-crystal  shows an increased in vitro rate of delivery of API 
into the aqueous environment of the dissolution media.59 
 
 
Figure 1-15 Changes of solubility of drug molecule with increase of the hydrophobicity of 
di acids58 
 1.3.2.2 Agrochemicals 
In the agrochemical industry, there is a need to design agrochemical active ingredients to 
meet the requirements of the 21st century. Co-crystallization has successfully assisted in 
achieving this goal through improved physical properties such as decreased solubility, improved 
melting points, and storage and formulation stability.60 Successful fine tuning of solubility of an 
agrochemical active cyprodinil, through co-crystallization is illustrated in Figure 1-16.12 
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Figure 1-16 Solubility profile of cyprodinil co-crystals12 
 
 1.3.2.3 Energetics 
Another successful application of co-crystallization can be found in the field of designing 
energetic materials. Even though this is still an emerging area, there are successful examples of 
using co-crystals to alter properties like impact and friction sensitivity and thermal stability of 
energetic materials.46, 61 One such example was reported by Matzger and co-workers, where a co-
crystal of two energetic materials, CL-20 and TNT was synthesized as a novel high-power, low-
sensitivity explosive.48 
 1.3.2.4 Organocatalysis 
Hydrogen bond based catalytic systems are widely applied in organocatalysis.62 Specially 
the involvement of thiourea based catalysts has shown many advantages in supramolecular 
chemistry.63 Similar to hydrogen bond based organocatalysts, halogen bond based 
organocatalysts are also effective in catalytic systems, through activation of an electrophile 
towards a nucleophilic attack owing to the directionality and selectivity of halogen bonds.64 In 
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one such example, iodine trichloride act as a halogen bond donor in catalyzing ring opening 
polymerization reaction of L-lactide by activating the carbonyl group65 (Figure 1-17). 
 
 
 
 
Figure 1-17 Halogen bond catalyzed ring opening polymerization of l-lactide65 
 
 1.4 Goals of the study 
An improved knowledge of intermolecular interactions is crucial in designing new solid 
forms with pre-determined connectivities. Controlled synthesis of supramolecular assemblies 
will lead to supramolecular networks with high prediction and hence control of the final 
structure-property relationships. 
The goals of this thesis are as follows, 
1. Finding the impact of electrostatic potential values in landscaping the structural 
outcomes in hydrogen and halogen bond based interactions in the solid state and implementing 
an electrostatic view for co-crystal synthesis. (Chapter 2) 
2. Designing new organocatalysts based on halogen bond donors. In this study concepts 
used in well-known hydrogen bond based organocatalysis will be extracted to design halogen 
based organo- catalytic systems. (Chapter 3) 
3. Exploring the effect of structural mimics in landscaping the structural outcomes of 
poorly soluble molecules. In this study, a poorly soluble API and a synthesized mimic is 
analyzed in terms of the structural behavior in the presence of FDA approved even-chain 
dicarboxylic acids (Chapter 4) 
16 
4. Application of co-crystallization technology to corrosive energetic materials to reduce 
chemical reactivity. In this study effect of nitrogen and oxygen based acceptors in modulating 
the performance and sensitivity of the energetic materials has studied. (Chapter 5) 
5. Decreasing the hygroscopicity of energetic materials through successful replacement 
of water molecules with suitable co-formers. Interaction of acidic N-H protons of the energetic 
material will be analyzed through different nitrogen and oxygen based acceptor molecules. 
(Chapter 6) 
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Chapter 2 - Impact of electrostatic potential calculations on 
predicting structural patterns in hydrogen and halogen bonding 
 
 2.1 Introduction 
 2.1.1 Importance of structural predictions 
Developing  new solid state structures with advanced physical and chemical properties is 
of great interest in crystal engineering.1 To understand the potential of crystalline materials it is 
important to correlate molecular structure with crystalline structure and macroscopic properties.2 
Predicting the crystal packing of a molecule is not asy,3 as there can be many possible 
arrangements, therefore it would be advantageous to design strategies to simplify structural 
predictions in crystal engineering. Crystal engineering is driven by non-covalent interactions like 
hydrogen4 and halogen bonding. These are widely studied and frequently used as synthetic 
vectors in molecular recognition events.5 Thus having precise control over hydrogen- bond 
formation can provide robust synthetic strategies for designing supramolecular architectures. In 
1990, Margaret Etter proposed  that “the best proton donors and acceptors remaining after 
intermolecular hydrogen- bond formation form bonds to one another”6,7 and this concept was 
illustrated by using an example of 2-aminopyrimidine-carboxylic acid co-crystals in which the 
ring nitrogen acceptors (better acceptor than acid carbonyl) form interactions with the acid O-H ( 
better donor than amino group hydrogens), and the second best donor (N-H protons) and 
acceptor (carbonyl oxygen) forms hydrogen- bond interactions, respectively (Figure 2-1). Etters’ 
work has been very important to current efforts for controlling and predicting the hydrogen- 
bond based structures and composition in molecular crystals.6 
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Figure 2-1 Aminopyrimidine-carboxylic acid co-crystal system governed by Etter’s best 
donor/acceptor concept6 
 
 2.1.2 Electrostatic potential approach 
Recently Hunter used calculated molecular electrostatic potential (MEP) values for rationalizing 
hydrogen bond preference. This method relies on the assumption that the long-range effect of 
electrostatic interactions play a key role in initial stages of molecular recognition compared to 
other forces like repulsion, induction and dispersion8. The maximum positive electrostatic 
potential value on the molecule is usually located close to an acidic hydrogen atom, and the most 
negative value is located over a lone pair or an area of π-electron density. The governing 
electrostatic interaction between two molecules is a pair- wise interaction which occurs between 
the minima and maxima of atoms.8 Therefore calculated electrostatic potential values (MEPs) on 
acceptors and donors can be employed as an effective method for estimating hydrogen- bond 
capability over a series of functionalities.9, 10  
Halogen bonds are also found in many supramolecular architectures which has led to the 
synthesis of many discrete and polymeric crystal arrangements.11 Being able to predict structural 
outcomes in halogen bond based molecular systems would be highly significant in crystal 
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engineering. Similar to hydrogen bonds, halogen bonds are also considered primarily 
electrostatic in nature.12 Murray and Politzer have shown that the electrostatic potential values 
computed on the halogens’ surfaces, along the σ-hole of the halogen atom, can be related to the 
strength of halogen bonds in RX halides13 (Figure 2-2). 
 
Figure 2-2 Changes of the strength of the σ hole with respect to the halide group14 
 
Also, Taylor and co-workers showed that systematic changes of the electronic properties 
of halogen-bond donors can affect the halogen-bond interactions in a molecular system.15 
Therefore it is reasonable to assume that the electrostatic component of halogen bonding makes 
supramolecular interactions amenable to similar MEP based rankings and binding preferences.   
Several effects have been made to find the robustness of calculated MEPs for predicting 
structural outcomes in halogen and hydrogen bond based supramolecular systems.9, 16, 17, 18 In 
these approaches, multi-component acceptor and donor groups were selected and the acceptor 
atoms with the highest negative electrostatic potential value was considered as the best acceptor 
and the donor atoms (halogen or hydrogen) with the highest positive MEP value was considered 
as the best donor group. Dominant intermolecular interactions were expected to occur between 
the best donor and the best acceptor groups. Figure 2-3 shows the application of calculated MEPs 
in predicting the structural outcome in a muticomponent donor system.9 In this study, the best 
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donor group (hydroxyl moiety) forms an interaction with the best acceptor and the second best 
donor (carboxylic acid moiety) forms an interaction with the second best acceptor. Figure 2-4 
shows structural predictions in a system with multiple acceptors. In this system, the best acceptor 
group (with highest negative MEP value) forms  a halogen-bond interaction leaving the second 
best acceptor site intact.18 In both examples it illustrates the best donor is determined by the 
highest positive electrostatic potential value and the best acceptor is determined by the highest 
negative electrostatic potential value.  
 
 
 
 
 
 
Figure 2-3 Best donor/acceptor interaction in a system with multiple donors16 
 
 
 
 
 
 
 
 
 
Figure 2-4 Best donor/acceptor interaction in a system with multiple acceptors18 
 
 
 
 
 
Best donor 
(191 kJ/mol) 
 Second best donor 
(138 kJ/mol) 
Second best acceptor  
( 132 kJ/mol) 
Best acceptor  
( 187 kJ/mol) 
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 2.1.3 Goal 
 Even though calculated MEPs values can be used for ranking acceptors and donors we do 
not know much about the details and limitations for using calculated MEPs of acceptors and 
donors before providing a label as a best donor or acceptor for intermolecular interactions. 
Previous attempts found that when the difference of calculated MEPs value between two 
acceptor sites is greater than 60 kJ/mol, the site with the highest negative potential has a higher 
tendency form a hydrogen or halogen bond interaction and is the best acceptor. But a difference 
of less than 30 kJ/mol was too small to be selective; both acceptors had equal chances to form 
interactions (Figure 2-5). In this study, we decided to find a boundary for MEPs values in 
ranking acceptor sites in multi component systems. With this in mind, two acceptor molecules 
A1 and A2 were synthesized (Figure 2-6). A1 had a MEPs difference of 38 kJ/mol and A2 had a 
difference of 26 kJ/mol between the competing acceptor sites. Since both A1 and A2 have 
nitrogen atoms as potential acceptors, hydrogen and halogen bond based donors were selected to 
examine the intermolecular interactions (Figure 2.7). In this study, we mainly focused on the 
nature of the calculated electrostatic potential values on acceptor atoms, thus the electrostatic 
nature of the donor molecules was not considered. 
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Figure 2-5 Possible structural outcomes of two acceptors (N1 and N2) in the presence of a 
donor molecule 
 
With this study, we are expecting to answer the following questions; 
1) Are these differences in MEPs large enough to obtain selectivity in forming 
intermolecular interactions? 
2) With these differences can we label one site as a best acceptor site over the other acceptor 
site? 
3) Can we obtain precise control in crystal arrangements with calculated MEP values in the 
presence of different donor molecules (Figure 2-7) 
 
 
 
 
 
 
 Figure 2-6 Acceptor molecules, A1 and A2 used in this study 
 
 
A1 A2 
a 
b 
c 
N1 and N2 have equal preference 
ΔN1: N2 < 30 kJ/mol 
N1 > N2: N1 is the best acceptor 
ΔN1:N2 >60 kJ/mol 
N2 > N1: N2 is the best acceptor 
ΔN1: N2 >60 kJ/mol 
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Figure 2-7 Donor molecules used in the co-crystallization experiments 
 
 2.2 Experimental  
Quinoline-2-carbaldehyde and pyridine-2-carbaldehyde were purchased from Aldrich and 
utilized without further purification. Hydrogen bond donors HB1- HB12, halogen bond donors 
XB1-XB5 and mixed donors D1 and D2 were purchased from commercial sources and used as 
received. Mixed donor D3 and D4 (Figure 2-7) were prepared according to reported procedures. 
[1,2,3]triazalo-[3,5-α]quinoline and [1,2,3]triazalo-[3,5-α]pyridine were synthesized following 
literature data. Melting points were measured using a Fisher-Johns melting point apparatus. 1H 
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NMR and 19FNMR spectra were reported using a Varian Unity plus 400 MHz spectrophotometer 
in CDCl3. IR spectra were recorded on a Nicolet 380 FT-IR. 
 2.2.1 Molecular electrostatic potential calculations 
Molecular electrostatic potential surfaces for A1 and A2 were obtained via density 
functional theory (B3LYP) using 6-31G* basis set in vacuum. All calculations were carried out 
using the Spartan’08 software. 
 2.2.2 Synthesis of acceptors and donors 
 2.2.2.1 Synthesis of [1,2,3]triazalo-[3,5-α] quinolone (A1)19  
 
 
 
 
 A mixture of quinolone-2-carboxaldehyde (17.5 mmol, 1.37 g) and hydrazine hydrate 
(206 mmol, 5.20 g, 5.00 ml) was heated under reflux in methanol (50 ml). Upon completion of 
the reaction (4h), the mixture was quenched with an aqueous solution of NaOH (20 ml, 30%) and 
the resulting mixture was extracted with dichloromethane (3X50 ml). The organic extracts were 
combined, washed with brine (20 ml) and dried over anhydrous MgSO4. The mixture was 
filtered and concentrated to get the corresponding hydrazone. The hydrazone was directly diluted 
in chloroform (20 ml), then activated manganese dioxide (42.0 mmol 1.85 g ) was added, heated 
under reflux (12h) and the resulting mixture was cooled to room temperature and filtered with 
celite. After concentrating the solution [1,2,3]triazalo-[3,5-α] quinoline was obtained as a yellow 
solid. 65% yield. Mp: 135-140oC (Lit value 144oC).  1HNMR (δH,400 MHZ,CDCl3) 8.13 (s 1H), 
8.84 (d 1H), 7.88 (d 1H) 7.77 (t 1H) 7.65 (m 2H), 7.56 (d 1H)  
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 2.2.2.2 Synthesis of  [1,2,3]triazalo-[3,5-α] pyridine (A2)20  
 
 
 
 
A mixture of pyridine-2-carboxaldehyde (17.5 mmol, 1.37 g) and hydrazine hydrate (206 
mmol, 5.20 g, 5.00 ml) was heated under reflux in methanol (50 ml). Upon completion of the 
reaction (4h), the mixture was quenched with an aqueous solution of NaOH (20 ml, 30%) and the 
resulting mixture was extracted with dichloromethane (3X 50 ml). The organic extracts were 
combined, washed with brine (20 ml) dried over anhydrous MgSO4. The mixture was filtered 
and concentrated to get the corresponding hydrazone. The hydrazone was diluted in chloroform 
(20 ml) then activated manganese dioxide (42 mmol 1.85 g) was added, heated under reflux 
(12h) and the resulting mixture was cooled to room temperature and filtered with celite. After 
concentrating the solution [1,2,3]triazalo-[3,5-α] pyridine was obtained as a yellow solid. 40% 
yield. M.p: 32-34 oC. (Lit value: 34-39oC). (1HNMR, 400 MHZ, CDCl3 δ H) 8.77 (s 1H) 7.74 (s 
1H) 7.27 (t 1H) 7.00 (m 1H) 
 2.2.2.3 Synthesis of D321 
 
 
 
To an oven dried one neck round-bottomed flask equipped with a stir bar, 1,4-diiodo-
2,3,5,6-tetrafluorobenzene (1.0 g,2.5 mmol) was added under a stream of N2 and the flask was 
sealed with a rubber septum. Freshly distilled THF (70 ml) was added via a cannula. This 
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solution was cooled to -78oC by immersing into dry ice-acetone bath for 5-7 min. To this 
solution n-butyllithium (1.6 M solutions in hexane, 1.7 ml, 2.6 mmol) was added slowly. After 
30 minutes, carbon dioxide gas was purged into the reaction mixture for 15 min followed by 
addition of excess solid dry ice. The reaction mixture was slowly warmed to 0oC and quenched 
with 2M HCl. The solvent was removed on a rotary evaporator and the product was extracted in 
methylene chloride. The organic layer was washed with saturated sodium thiosulfate solution, 
brine solution and dried over anhydrous MgSO4. Solvent was removed on a rotary evaporator to 
get the crude product and after washing with hexane the pure product was obtained in 52 % 
yield. (0.414 g, M.p. 130-135oC) (Lit value 140oC)21 (19FNMR, 400 MHZ, CDCl3 δ F) -121.33 
(2F) -139.89 (2F) 
 2.2.2.4 Synthesis of D421 
 
 
 
To an oven-dried round-bottomed flask equipped with a stir bar, 1,4-dibromo-2,3,5,6-
tetrafluorobenzene (1.0 g,2.5 mmol) was added under a stream of N2 and the flask was sealed 
with a rubber septum. Freshly distilled THF (70 ml) was added via a canula. This solution was 
cooled to -78oC by immersing it into dry ice-acetone bath for 5-7 min. To this solution, n-
butyllithium (1.6 M solutions in hexane,1.7 ml, 2.6 mmol) was added slowly. After 30 minutes 
carbon dioxide gas was purged into reaction mixture for 15 min followed by addition of excess 
solid dry ice to the reaction mixture. The reaction mixture was slowly warmed to 0oC and 
quenched with 2M HCl. The solvent was removed on a rotary evaporator and product was 
extracted in methylene chloride. The organic layer was washed with saturated sodium thiosulfate 
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solution, brine solution and dried over anhydrous MgSO4. The solvent was removed on rotary 
evaporator to get the pure product in 86 % yield. (0.764 g, M.p 128-130oC, Lit value 128-
130oC)21 (19FNMR, 400 MHZ, CDCl3 δ F) -131.72 (2F) -137.14 (2F) 
 2.2.3 Synthesis of co-crystals22 
[1,2,3]Triazalo-[3,5-α] quinoline (A1) and [1,2,3]triazalo-[3,5-α] pyridine (A2) were 
subjected to co-crystallization against twelve hydrogen bond donors, five halogen bond donors 
and four mixed donors (Figure 2.7). Donors and acceptors were combined according to the 
stoichiometric ratio and ground together with a drop of methanol until a solid paste was obtained.  
The resulting solid was then analyzed via IR spectroscopy for product formation. This procedure 
was continued for all 42 experiments and X-ray quality single crystals were obtained by 
dissolving the ground mixture in suitable solvents and allowing slow evaporation or vapor 
diffusion method. (Eight co-crystals produced single crystals suitable for single-crystal X-ray 
diffraction) 
 2.2.3.1 Synthesis of [1,2,3]triazalo-[3,5-α] quinoline pentafluoroiodobenzene, A1:XB1 
A1 (0.010 g, 0.060 mmol) was dissolved in 1 mL of ethyl acetate. To this solution 
pentafluoroiodobenzene (0.035 g, 0.12 mmol) in 1 mL of ethyl acetate was added. The resulting 
solution was left for slow evaporation in a 2-dram borosilicate vial at room temperature. 
Colorless prism-shaped crystals were obtained within one week. M.p 85-90oC. 
 2.2.3.2 Synthesis of  di-[1,2,3]triazalo-[3,5-α] quinoline 1,4-diiodoterafluorobenzene, 
(A1)2:XB4 
A1 (0.010 g, 0.060 mmol) was dissolved in 1 mL of ethyl acetate. To this solution 1,4-
diiodotetrafluorobenzene (0.024 g, 0.060 mmol) in 1 mL of ethyl acetate was added. The 
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resulting solution was left for slow evaporation in a 2-dram borosilicate vial at room 
temperature. Bronze color plate shaped crystals were obtained within one week. M.p78-84oC. 
 2.2.3.3 Synthesis of di-[1,2,3]triazalo-[3,5-α] quinolineadipic acid, (A1)2:HB2 
A1 (0.010 g, 0.060 mmol) and adipic acid (0.004 g, 0.029 mmol) was dissolved in 2 mL 
of methylenechlorid in a 2-dram borosilicate vial at room temperature. The open vial was kept in 
a closed container with 4 mL of hexane and left for vapor diffusion. Colorless plate shaped 
crystals were obtained within one week. M.p100-110oC. 
 2.2.3.4 Synthesis of di- [1,2,3]triazalo-[3,5-α] quinoline glutaric acid, (A1)2:HB6 
A1 (0.010 g, 0.06 mmol) was dissolved in a 1 mL of methanol. To this solution glutaric 
acid (0.039 g, 0.029 mmol) in 1 mL of methanol was added. The resulting solution was left for 
slow evaporation in a 2-dram borosilicate vial at room temperature. Colorless needle shaped 
crystals were obtained within one week. M.p75-80oC. 
 2.2.3.5 Synthesis of [1,2,3]triazalo-[3,5-α] quinoline 2-fluorobenzoic acid, A1:HB9 
A1 (0.010 g, 0.06 mmol) was dissolved in a 1 mL of methanol. To this solution 2-
fluorobenzoic acid (0.0082 g, 0.06 mmol) in 1 mL of methanol was added. The resulting solution 
was left for slow evaporation in a 2-dram borosilicate vial at room temperature. Bronze color 
prism shaped crystals were obtained within one week. M.p 62-70oC. 
 2.2.3.6 Synthesis of di-[1,2,3]triazalo-[3,5-α] quinoline tetrafluoro-4-iodobenzoic acid, 
(A1)2:D3 
A1 (0.010 g, 0.060 mmol) and tetrafluoro-4-iodobenzoic acid (0.010 g, 0.029 mmol) was 
dissolved in 2 mL of methylenechloride in a 2-dram borosilicate vial at room temperature. The 
open vial was kept in a closed container with 4 mL of hexane and allowed for vapor diffusion. 
Bronze color plate shaped crystals were obtained within one week. M.p115-120oC. 
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 2.2.3.7 Synthesis of [1,2,3]triazalo-[3,5-α] pyridine and 1,2-diiodotetrafluorobenzene, 
A2:XB2 
A2 (0.010 g, 0.084 mmol) and 1,2-diiodotetrafluorobenzene (0.067 g, 0.17 mmol) was 
dissolved in 2 mL of methylenechloride in a 2-dram borosilicate vial at room temperature. The 
open vial was kept in a closed container with 4 mL of hexane and left for vapor diffusion. 
Colorless prism-shaped crystals were obtained within one week. M.p 55-60oC. 
 2.2.3.8 Synthesis of [1,2,3]triazalo-[3,5-α] pyridine and 1,3,5-triiodotrifluorobenzene, 
A2:XB3 
A2 (0.010 g, 0.084 mmol) was dissolved in a 1 mL of methanol. To this solution 1,3,5-
triiodotrifluorobenzene acid (0.085 g, 0.168 mmol) in 1 mL of methanol was added. The 
resulting solution was left for slow evaporation in a 2-dram borosilicate vial at room 
temperature. Colorless prism-shaped crystals were obtained within one week. M.p 105-110oC. 
 2.2.4 Single crystal X-ray crystallography 
All datasets were collected on a Bruker APEX II system using MoKα radiation. Data 
were collected using APEX2 software. Initial cell constants were found by small widely 
separated “matrix” runs. Data collection strategies were determined using COSMO. Scan speed 
and scan widths were chosen based on scattering power and peak rocking curves. All datasets 
were collected at -153°C using an Oxford Cryostream low-temperature device. Unit cell 
constants and orientation matrix were improved by least-squares refinement of reflections 
thresholded from the entire dataset. Integration was performed with SAINT,using this improved 
unit cell as a starting point. Precise unit cell constants were calculated in SAINT from the final 
merged dataset. Lorenz and polarization corrections were applied. Multi-scan absorption 
corrections were performed with SADABS. Data were reduced with SHELXTL. The structures 
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were solved in all cases by direct methods without incident. Except as noted, hydrogen atoms 
were located in idealized positions and were treated with a riding model. All non-hydrogen 
atoms were assigned anisotropic thermal parameters. Refinements continued to convergence, 
using the recommended weighting schemes. In A1:HB9 the asymmetric unit contains one 
molecule each of the triazole-based ligand and aromatic carboxylic acid. The aromatic 
carboxylic acid molecule is disordered over two closely related positions. The same coordinates 
have been utilized for atoms occupying the same site using the EXYZ command. Thermal 
parameters for closely located atoms were pairwise constrained using the EADP command. 
Coordinates of the carboxylic acid proton H31 was allowed to refine.  In (A1)2 :HB6 and (A1)2 
:HB2 Coordinates of the carboxylic acid proton H31 was allowed to refine.  In (A1)2:D3 the 
asymmetric unit contains two molecules of the triazole-based ligand and one molecule of the 
aromatic carboxylic acid. The aromatic carboxylic acid molecule is disordered over two closely 
related positions, thus representing different orientations. Relative populations were allowed to 
refine. Thermal parameters for closely located atoms were pair-wise constrained using EADP 
commands. Geometry of the aromatic ring was restrained using the SAME command. The bond 
distances were fixed to idealized distances using the DFIX command 
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 2.3 Results 
 2.3.1 Molecular electrostatic potential values 
Electrostatic potential values of A1 showed -209 kJ/mol and -171 kJ/mol values on N1 
and N2, respectively, a difference of 38 kJ/mol between the two acceptor sites. A2 showed MEPs 
of -206 kJ/mol and -180 kJ/mol on N1 and N2 respectively with a difference of 26 kJ/mol. 
(Figure 2-8) 
 
Figure 2-8 Calculated MEP values of A1 and A2 
 
 2.3.2. Grinding and IR analysis 
A1 and A2 were initially screened for co-crystal formation using liquid assisted grinding 
followed by IR spectrometric characterization of the product. Two broad bands around 1850-
2450 cm-1, indicative of the formation of intermolecular O-H……N hydrogen bonds,23 were used 
as the primary markers for determining co-crystal formation (Figure 2-9).  
 
A1 
A2 
 
-171 kJ/mol -209 kJ/mol 
 Δ 38 kJ/mol 
-180  kJ/mol 
-206 kJ/mol 
Δ 26 kJ/mol 
N1 N2 N1 
N2 
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Figure 2-9 IR spectrum of (A1)2:HB6 (middle) with broad bands indicating intermolecular 
O-H---N interactions (black circle) 
 
Co-crystals with halogen bonds were confirmed by significant changes to several IR stretches in 
the ground mixture compared to the spectra of the pure acceptor and donor compounds. 33 of the 
42 reactions produced co-crystals. 
Table 2-1 IR table of grinding experiments of A1 and A2, ✓ indicates a positive result and 
 indicates a negative result 
Hydrogen bond donors A1 A2 Halogen bond donors A1 A2 
Succinic acid (HB1) ✓ ✓ Pentafluoroiodobenzene (XB1) ✓ ✓
 
Adipic acid (HB2) ✓ ✓ 1,2-Diiodotetrafluorobenzene (XB2)  ✓
 
Suberic acid (HB3) ✓ ✓ 1,3,5-Triiodotriflurobenzene (XB3) ✓
 ✓ 
Sebacic acid (HB4) ✓ ✓ 1,4-Diiodotetrafluorobenzene (XB4) ✓
 ✓ 
Dodecanedioic acid (HB5) ✓ ✓ 4,4'-Diiodo-1,1'- ✓
  
HB6 
  A1:HB6 
A1 
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biphenyloctafluorobenzene (XB5) 
Glutaric acid (HB6) ✓ ✓ Mixed donors A1 A2 
Pimelic acid (HB7)  ✓ 4-Iodotetrafluorophenol (D1) ✓ ✓ 
Azaleic acid (HB8)   4-Bromotetrafluorophenol (D2) ✓ ✓ 
2-Fluorobenzoic acid (HB9) ✓ ✓ 4-Iodotetrafluorobenzoic acid (D3) ✓ ✓ 
2-Nitrobenzoic acid (HB10) ✓ ✓ 4-Bromotetrafluorobenzoic acid (D4) ✓ ✓ 
4-Hydroxybenzoic acid (HB11)   
Benzoic acid (HB12)   
  
 2.3.3 Analysis of the crystal structures 
Even though co-crystal analysis through IR spectroscopy provides unambiguous 
confirmation of intermolecular hydrogen or halogen bond formation, it does not allow us to 
determine how the two reactants bind. To understand the molecular interactions, X-ray 
crystallography was carried out. Figure 2-10 shows the predicted structural outcomes of A1 and 
A2 with different donors. 
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Figure 2-10 Predicted structural outcomes of A1 and A2: (a) no binding preference for N1 
and N2 acceptor sites (b) shows a binding preference for best acceptor N1 
  
 2.3.3.1Crystal structure of A1:XB1 
  The crystal structure of A1:XB1 was obtained in a 1:1 stoichiometry. The structure 
showed a discrete architecture with the formation of a halogen bond between an activated iodine 
atom and N1 from the acceptor with the highest electrostatic potential value. The N2 acceptor 
atom with the lowest electrostatic potential value does not participate in any significant halogen- 
bond interaction (Figure 2-11).  
 
 Figure 2-11 N---I halogen bond formed between N1 and XB1 
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 2.3.3.2 Crystal structure of (A1)2:XB4 
In the crystal structure of (A1)2:XB4 both iodine atoms in the ditopic halogen bond 
donor, form  halogen bonds with N1 (highest electrostatic potential value). Similar to the 
previous structure N2 (with the lowest electrostatic potential value) does not form any significant 
halogen bonds or short contacts (Figure 2-12). 
 
Figure 2-12 XB4 forms N----I halogen bonds with N1  
 
 2.3.3.3 Crystal structure of (A1)2:HB2 and (A1)2:HB6 
  The crystal structure of A1 with both HB2 and HB6 showed a 2:1 stoichiometry. Similar 
to halogen- bond interactions both ditopic carboxylic acids forms discrete architecture via O-H---
N interactions with N1. N2 did not participate in any significant hydrogen-bond interaction 
(Figure 2-13). 
 
 
 
 
  
 
 
Figure 2-13 O-H----N hydrogen-bond interaction formed between N1 and –OH group of 
the carboxylic acids (top: (A1)2:HB2 and bottom :(A1)2:HB6) 
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 2.3.3.4 Crystal structure of (A1):HB9  
  The crystal structure of A1 with HB9 showed 1:1 stoichiometry, with O-H---N hydrogen 
bond interaction between the acceptor site N1 leaving the second-best acceptor site intact (Figure 
2-14). 
 
Figure 2-14 O-H----N hydrogen-bond formation between N1 and O-H in (A1):HB9 
 
 2.3.3.5 Crystal structure of (A1)2:D1 
 The crystal structure of A1 with D1 showed 2:1 stoichiometry and this structure again 
led to a discrete architecture. The iodine atom and the O-H group formed N---I and O-H---N 
interactions respectively. This structure shows that both hydrogen and halogen based donors 
prefer to form intermolecular interactions with the best acceptor site N1 (Figure 2-15). 
 
 
 
 
Figure 2-15 O-H---N and N---I interactions formed by –OH and I groups, respectively with 
N1 of A1 
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 2.3.3.6 Crystal structures of A2:XB2 and A2:XB3 
The Crystal structure of A2 with XB2 and XB3 showed that, both nitrogen atoms in A2 
form halogen bonds. There is no selectivity in forming non-covalent interactions even though N1 
has a higher positive electrostatic potential value. However, there was a significant difference in 
the bond lengths of the halogen-bond interactions formed by N1 and N2. The N1----I bond is 
shorter than the N2---I interactions. (A2:XB2, 2.907(4), 2.9883(3), respectively and A2:XB3, 
2.845 (3),2.992 (3) respectively. This data suggests that halogen-bond interaction with the best 
acceptor (site with the highest positive electrostatic potential) is stronger than the interaction 
with the second-best acceptor (Figure 2-16). 
 
Figure 2-16 Crystal structure of A2:XB2 (right) and A2:XB3 (left) with N1----I and N2----I 
halogen-bond interactions 
Table 2-2 Bond lengths and angles of hydrogen bonds in the crystal structures 
Compound  D-H (Å) H----A (Å) D----A (Å) DH-A (o) 
(A1)2:HB6 O(31)-H(31)---N(13) 1.00(3) 1.68(3) 2.679(3) 175(3) 
(A1)2:HB2 O(31)-H(31)---N(13) 0.940(16) 1.767(16) 2.7022(13) 172.5(14) 
A1:HB9 O(31)-H(31)---N(13) 1.006(18) 1.652(18) 2.6544(15) 173.2(16) 
(A1)2:D3 
O(51A)-H(51A)----N(13) 
O(51B )-H(51B )---N(33) 
0.84 
0.84 
1.89 
1.92 
2.725(3) 
2.751(6) 
175.1 
73.1 
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Table 2-3 Bond lengths and angles of halogen bonds in the crystal structures 
Compound  X----A (Å) DX—A (o) 
A1:XB1 N(13)---I(1) 3.0662(17) 167.49(6) 
(A1)2:XB4 N(13)---I(1) 2.99379(14) 175.98(5) 
A2:XB2 
N(12)---I(1) 
N(13)---I(2) 
2.988(3) 
2.907(4) 
171.93(13) 
179.53(13) 
A2:XB3 
N(13)---I(1) 
N(12)---I(2) 
2.845(3) 
2.992(3) 
177.31(10) 
173.32(11) 
  
 2.4 Discussion 
 2.4.1 Hydrogen and halogen bond prediction through IR spectroscopy 
Co-crystal analysis of A1 and A2 with hydrogen and halogen bond donors was initially 
carried out through IR spectroscopy. In this study, donor molecules with carboxylic acid groups 
were primarily chosen as the hydrogen-bond donors and the fluorinated iodine carrying 
molecules were chosen as the halogen-bond donors. Therefore, changes of the main functional 
groups in both halogen and hydrogen bond donors can be used as indicative of co-crystal 
formation. In the hydrogen bonded networks co-crystal formation were mainly identified through 
characteristic double “humps” for O-H---N interaction which appeared in 1800-2200 cm-1 and 
2300-2600 cm-1 region.  
 2.4.2 Interpretation of the structural outcomes 
A1 and A2 both contain two possible acceptor sites. The analysis of the crystal structures 
of A1 showed that with both halogen and hydrogen bond donors the acceptor site with the 
highest electrostatic potential value (-206 kJ/mol) had a preference for forming an intermolecular 
interaction over the acceptor site with the lower electrostatic potential value (Figure 2-17). 
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Figure 2-17 Structural outcomes of A1 and A2 in co-crystallization experiments 
 
Even though the difference between two acceptor sites is only38 kJ/mol it is still enough 
to make one acceptor site preferred over the other. This conclusion was supported by all six 
crystal structures. Two co-crystals of A2 (with a potential difference of 26 kJ/mol) suitable for 
X-ray diffraction were obtained with halogen bond donors. In the crystal structures of A2:XB2 
and A2:XB3, both nitrogen atoms participated in halogen bonding indicating that the 
electrostatic potential difference between two acceptor sites is not large enough to make one site 
structurally dominant. This observation was consistent with previous results which showed that 
MEPs difference < 30 kJ/mol is strong not enough to make structural selectivity. 
 2.4.3 Elimination of a geometrical explanation for selectivity in A1 
Even though the understanding all six crystal structures of A1 underscores the importance 
of MEPs in predicting outcomes of potential competing non-covalent interactions it was possible 
that this supramolecular selectivity was the result of some geometric factor which prevented the 
second nitrogen atom from participating in forming either a hydrogen or a halogen bond. 
However the crystal structure of A1 by itself shows that both nitrogen atoms in A1 are available 
for hydrogen- bond formation, which include C-H---N (best acceptor) and C-H---N (second best 
acceptor) hydrogen bonds (Figure 2-18). 
 
Binding preference only for N1
Binding preference for both N1 and N2
6/6 outcomes
2/2 outcomes
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Figure 2-18 Crystal structure of A1 showing that both N1 and N2 are capable in forming 
intermolecular interactions 
 
This suggests that there is no inherent geometric barrier in this molecule which would 
prevent it from forming a halogen/ hydrogen bonds with N2. Therefore, as N1 is engaged in 
hydrogen bonds in all six co-crystals of A1 the results correlate with the calculated MEPs values. 
 2.5 Conclusion 
  Our experimental data suggest that a simple electrostatic approach for ranking different 
interaction sites provides reliable guidelines in predicting outcome of competing non-covalent 
interactions. We have not carried out extensive polymorph screening for each supramolecular 
reaction, however we assume that the molecular preferences showed by A1 and A2 will not 
change drastically even if several new structures were to be added. The analysis of A1 by itself 
showed that both acceptor atoms are accessible to form non-covalent interactions. This 
observation confirms that the outcomes are not related to the steric effect of the molecules. 
To summarize our results, 
1) The electrostatic potential difference of 38 kJ/mol is enough to produce selectivity 
within the structural landscapes in multitopic acceptors, but the selectivity is lost 
when this difference is < 30 kJ/mol 
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2) With the difference of 38 kJ/mol the acceptor site with the highest electrostatic 
potential value can be labeled as the best acceptor, but with a difference of < 30 
kJ/mol both acceptor sites have equal preference in XB/HB interactions 
3) Crystal structures of A1 and A2 with different halogen and hydrogen bond donors 
showed 6/6 and 2/2 structural outcomes, respectively showing that calculated 
MEPs values can be used for successful structural outcome predictions. 
 
 
 
Figure 2-19 Overview of the structural outcomes with new boundaries 
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Chapter 3 - Halogen-bond based organocatalysis: An alternative to 
hydrogen-bond based catalysis 
 
 3.1 Introduction 
 3.1.1. Organocatalysis by hydrogen bonding 
Organocatalysis is referred to as the use of small organic molecules to catalyze organic 
transformations, and the emergence of this type of catalysis has huge impact on organic synthesis 
over the last two decades.1 Organic catalysis has had many advantages compared to the classic 
metal- based catalysis: it is cheap, non-toxic and insensitive to moisture and air. Due to these 
properties, organocatalysis is attractive to the scientific community, particularly in the 
pharmaceutical industry where the presence of metal ions causes problems in-vivo.2 Activation 
of substrates through organocatalyis is mainly divided into two categories:3covalent catalysis and 
non-covalent catalysis4 (Figure 3-1). 
 
 
 
  
 
 
 
 
Figure 3-1 Two main categories of organocatalysis 
Organocatalysis 
Covalent organocatalysis 
 
 
Non-covalent organocatalysis 
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  The most powerful non-covalent interaction used to date is hydrogen bonding and 2,3 
most common hydrogen-bond based concepts in organocatalysis are bidentate functional groups, 
mainly with thiourea derivatives dominating the field. Figure 3-2 shows two examples of 
thiourea based organocatalysis which uses two different concepts of modes of activation. First 
example is a benchmark Diels-Alder reaction, where the hydrogen-bond donors bind to the 
carbonyl moiety and activates the substrate through electron withdrawal.5 Second example shows 
the binding of anions (mainly halides) released during the course of an SN1-type reaction.
6 
Removal of anions through hydrogen- bond formation enhances the product formation by 
increasing the reaction rate. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-2 Two examples of hydrogen-bond based organocatalysis 1. Based on the 
activation of a carbonyl compound 2. Based on the activation through halide abstraction5, 6 
 
 
 
 
1. 
2. 
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 3.1.2 Comparison of hydrogen and halogen bond based systems 
Even though halogen bonds are considered as a close kin to hydrogen bonds, there are 
some distinctive features which make halogen bonds more suitable in organocatalysis. Halogen 
bonds are more directional (R-X----LB ~ 180oC) than hydrogen bonds, which is due to the 
repulsion of halogen lone pairs with the Lewis base at obtuse angles. Also halogen bonding 
provides more tunability than hydrogen bonding, with the availability of four principle halogen 
atoms (F,Cl,Br,and I).7 Lewis acidity of halogen bond donors increases in the order of Cl<Br<I 
with the increase of polarizability.8, 9 However there are very few examples of fluorine acting as 
a halogen-bond donor10 and interactions are mainly based on iodine-based halogen-bond donors. 
With the increase of electronegativity of the halogen bearing substituent, more Lewis- acidic 
halogen-bond donors are produced and mostly polyfluorinated or cationic moieties are used as 
backbones (Figure 3-3). 
 
 
 
 
 
 
Figure 3-3 Common backbones used in halogen-bond based adducts; (a) fluorinated 
backbone (b) cationic backbone  
 
Since polyfluorinated halogen-bond donors are apolar, they may be used for applications that 
rely on low polarity, whereas the hydrogen-bond based systems are often considered as polar 
with the presence of polar –OH or –NH groups.11 Another prominent difference in halogen-bond 
based systems is the electronic nature of the hydrogen and halogen atoms. Since hydrogen and 
iodine reside on the opposite ends of the periodic table, there is a significant difference in orbital 
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size and polarizability. Therefore hydrogen-bond based systems and halogen-bond based systems 
can be used for different classes of Lewis bases in organocatalysis.9 
 3.1.3 Concept use in halogen-bond based catalysis 
Similar to thiourea based catalysts, we can use mono or multidentate halogen-bond 
donors as Lewis acidic activators (catalysts), however using mulidentate donors is more 
advantageous since these molecules bind more strongly to the substrate and create a more rigid 
structure. Figure 3-4  shows the concept transfer of hydrogen-bond donors and halogen bond 
donors in a multidentate system.9 
 
Figure 3-4 Concept transfer from a hydrogen-bond based system to a halogen-bond based 
system 
In the anion-bonding approach, halogen-bond donors interact with the leaving anion which is 
formed during a SN1 reaction. With the removal of the anion the reaction will be accelerated, 
however the liberated anion binds strongly to the halogen-bond donors and there is a strong risk 
of catalyst inhibition and catalytic transformation requires special reaction design9 (Figure 3-5). 
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Figure 3-5 Mode of activation through halide abstraction 
 
 3.1.4 Examples of halogen based organocatalysis 
Even though halogen based organocatalysis provides a new avenue in organic chemistry 
there are only few multidentate halogen-bond donors reported and the synthesis and design is 
significantly challenging due to the limited availability of backbones. Therefore halogen-bond 
based catalysis is still an emerging area. In most of the early studies, evidence of activation of 
substrates through halogen bonding was not clearly reported as they were unable to rule out the 
hidden acid based catalysis and the exact mode of action was not properly understood.12 
However in recent studies Huber and his co-workers reported on a few examples of halogen-
based organocatalysis, ruling out other possible substrate activations and provide significant 
evidence for catalysis, purely based on halogen- bond donors. They synthesized different 
cationic and neutral halogen-bond donors which were applied to many bench mark reactions to 
observe the effect of halogen-bond donors in catalysis (Figure 3-6).9, 13, 14 
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Figure 3-6 Examples of cationic and polyfluorinated backbones used in halogen-based 
catalytic systems. 
  
In one such example, activation of carbonyl compounds through halogen bonding was 
reported using a benchmark Diels-Alder reaction. In this study, cationic halogen-based catalysts 
were used in the presence of non-coordinating BAr4F
- anion. A 63 % product formation was 
formed, compared to a thiourea- based catalyst, which produced only 38 % (Figure 3-7 and 3-8). 
 
 
 
 
 
 
Figure 3-7 Benchmark Diels-Alder reaction for catalytic studies based on halogen bonding 
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Figure 3-8 Proposed mechanism of carbonyl activation through halogen bonding 
 
Although the first steps were taken towards designing halogen-based catalysts, it is still 
underdeveloped. Therefore, it is important to develop suitable catalysts and reaction conditions 
using the knowledge of existing solid state crystal structures to apply the concept of halogen-
based catalysis into more complex structures. 
 3.1.5 Goals of this study 
With increasing demand for halogen–bond based catalysis as an alternative to well-
known hydrogen-bond based catalysis, we decided to apply our knowledge in designing halogen 
based supramolecular synthons for solid state applications to solution based studies to design an 
effective catalytic system. 
The goals are, 
1) To synthesize a suitable halogen-based catalyst 
2) To observe the catalytic activity in a benchmark reaction through anion 
recognition mechanism 
3) To eliminate possible hidden catalysis and confirm the feasibility of halogen bond 
donors in the catalysis using control molecules 
 
57 
 3.2 Experimental 
All the chemicals were purchased from available commercial sources and used without 
further purification.1H NMR was reported using a Varian Unity plus 400 MHz 
spectrophotometer in CDCl3. IR Spectroscopy was carried out on a Nicolet 380 FT-IR. Melting 
points were measured on Fisher-Johns melting point apparatus.  
 3.2.1 Synthesis of a new halogen- bond based catalyst (L1) 
A new class of catalyst was designed based on an iodine group as a halogen-bond donor. 
The iodine group was activated by attaching to a sp hybridized carbon atom. To compare the 
catalytic activity of the activated halogen-bond donor, two control molecules, one without any 
halogen atom and another molecule without activating the halogen atom was synthesized. After 
successful synthesis, catalytic activity was analyzed on a benchmark Ritter-type solvolysis 
reaction. 
 
 
 
 
  
  
  
  
 
Figure 3-9 Reaction scheme for the synthesis of L1 
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 3.2.1.1 Synthesis of 3-((trimethylsilyl)ethynyl)benzaldehyde 
 
 
 
 
 
 
To a one-neck round-bottom flask equipped with a stir bar, 3-bromobenzaldehyde (1.89 mL, 
0.0162 mmol) and 150 mL of triethyl amine were added and degassed with nitrogen gas for 20 
mins. To the reaction mixture (0.113 g, 0.162 mmol) of bis(triphenylphosphine)palladium(II) 
dichloride and (0.0600 g, 0.324 mmol) of CuI was added followed by the addition of 
trimethylsilyl acetylene (2.5 mL,0.0178 mol). Nitrogen gas was bubbled through the mixture for 
an additional 30 min until the reaction medium was saturated and the reaction was stirred at 
room temperature for 24 hours. Upon the completion of the reaction (confirmed by TLC), the 
solvent was removed by rotary evaporator. The resulting solid was extracted in CHCl3, washed 
with brine and dried over anhydrous Mg2SO4. The organic layer was removed in a rotary 
evaporator and the pure product was obtained as a brown color liquid (43%) after column 
chromatography with hexane. (1HNMR, CDCl3, δH) 9.98 (s 1H), 7.96 (s 1H), 7.81 (d 1H) 7.69 (d 
1H) 7.47 (t 1H) 
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 3.2.1.2 Synthesis of 3-(iodoethynyl)benzaldehyde 
  
 
 
 
 
 
To a one-neck round-bottom flask equipped with a stir bar, 3-trimethylsilyl benzaldehyde 
(1.4 g, 6.9 mmol) and 0.87 g (6.9 mmol) of silverfluoride was added followed by the addition of 
75 mL of acetonitrile. The flask was then wrapped with aluminum foil and the stirring was 
continued for 24 hrs. The reaction mixture was then passed through a silica plug using 
acetonitrile and concentrated using a rotary evaporator.  The resulting solid was then extracted in 
diethyl ether and washed with water. After concentration, pure yellow color product was 
obtained in 88% yield. (1.50 g) M.p 95-100oC, 1HNMR, CDCl3, δ H) 9.99 (s 1H) 7.94 (d 1H) 
7.82 (d 1H) 7.68 9d 1H) 7.51 (t 1H)    
 3.2.1.3 Synthesis of N,N’-(cyclohexane-1,2-diyl)bis(1-(3- 
iodoethynyl)phenylmethanimine (L1) 
  
 
 
 
 
 
To 0.068 g (0.60 mmol) of 1,2-diaminocyclohexane, 100 mL of ethanol was added and 
heated to 70oC for 10 min. To this a solution of 3-(iodoethynyl)benzaldehyde (0.30 g, 1.2 mmol) 
was added and heated under reflux for 2 hrs. The reaction mixture was cooled and the volume 
60 
was reduced to half using a rotary evaporator. To the reaction 200 mL of water was then added 
to induce precipitation. The resulting solid was filtered and redissolved in 120 mL of methylene 
chloride, washed with distilled water and brine. The organic layer was evaporated and the 
resulting brown color solid was collected in 60 % yield. M.p 60-65oC (1 HNMR, DMSO-d6 δ H) 
8.18 (s 1H) 7.62 (d 2H) 7.41(d 1H) 7.34 (t 1H) 3.18 (s 1H) 15-1.8 (m 5H) 
 3.2.1.4 Synthesis of N,N'-(cyclohexane-1,2-diyl)bis(1-phenylmethanimine) (L1-phenyl) 
 
 
 
 
 
To 1,2-diaminocyclohexane (0.23 g, 2.0 mmol) 100 mL of ethanol was added and heated 
to 70o for 10 min. To the reaction mixture, 0.42 g, 4.0 mmol of benzaldehyde was added and 
heated under reflux for 2 hrs. The volume was reduced to half using a rotary evaporator and to 
the reaction mixture was then added 200 mL of water to induce precipitation. The resulted solid 
was redissolved in 120 mL of methylene chloride, washed with water and brine. After 
concentrating the organic layer, the product was obtained in 80% yield as a white solid. M.p 115-
120oC (1HNMR DMSO-d6 δ H) 8.18 (s 1H) 7.60 (m 3H) 7.35(m 2H) 3.41(s 1H) 1.45-1.85 (m 
4H) 
 3.2.1.5 Synthesis of N,N'-(cyclohexane-1,2-diyl)bis(1-(3-chlorophenyl)methanimine) 
(L1-Chloro) 
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To 1, 2-diaminocyclohexane (0.11 g, 1.0 mmol) 100 mL of ethanol was added and heated 
to 70o for 10 min. To the reaction mixture 0.25 g, 2.0 mmol of 3-chlorobenzaldehyde was added 
and heated under reflux for 2 hrs. The volume was reduced to half using a rotary evaporator and 
to the reaction mixture 200 mL of water was added to induce precipitation.  The resulting solid 
was re-dissolved in 120 mL of methylene chloride, washed with water and brine. After 
concentrating the organic layer product was obtained in 75% yield as a white solid. M.p 95-
100oC (1HNMR DMSO-d6 δ H) 8.18 (s 1H) 7.61 (d 2H) 7.39 (d 2H) 3.34 (s 1H) 1.42-1.77 (m 
4H) 
 3.2.2 Analysis of the catalytic activity 
Catalytic activity of L1, L1-Chloro and L-Phenyl were measured using the benchmark 
Ritter-type solvolysis of benzhydryl bromide in acetonitrile. (The benchmark Diels-Alder 
reaction was not studied due to the poor solubility of L1 in methylene chloride) (Figure 3-10). 
 
  
 
Figure 3-10 Benchmark Ritter type solvolysis of the benzhydryl bromide 
 
 3.2.2.1 Initial screening of the catalytic activity 
 Benzyhydryl bromide (0.0098 g, 0.0040 mmol) was dissolved in 0.5 mL of 
CD3CN at room temperature in a 2-dram borosilicate vial. L1 0.020 g, (100 %) 0.040 mmol 
dissolved in 0.5 ml of CD3CN was then added and the reaction was stirred at room temperature 
for 24 h, 48 h, 72 h and 96 h. Temperature was kept constant by keeping the reaction mixture in 
a water bath. At each time interval, the reaction progress was monitored using 1H NMR 
spectroscopy.  The procedure was repeated using 0.0020 g (10 %) and 0.0040 g (20%) of L1 to 
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observe the changes of activity with respect to the amount of catalyst. Each experiment was 
performed three times. The reaction progress without any catalyst was analyzed by dissolving 
0.0098 g of benzhydryl bromide in 1 mL of CD3CN and stirring at room temperature without any 
catalyst for 24 h, 48 h, 72 h and 96 h. Reaction progress was analyzed using 1H NMR 
spectroscopy. Reaction was carried out with L1-Phenyl and L1-Chloro to observe any catalytic 
activity without halogen-bond donors as activating agents. Benzyhydryl bromide (0.0098 g, 
0.040 mmol) was dissolved in 0.5 mL of CD3CN in a 2-dram vial and to the mixture 0.014 g 
(stoichiometric amount) of L1-Chloro in 0.5 mL of CD3CN was added.  The reaction was stirred 
at room temperature for 24 h, 48 h, 72 h and 96 h. Reaction progress was monitored using 1H 
NMR spectroscopy. The reaction was repeated for L1-phenyl (0.012 g, stoichiometric amount) 
following the same procedure. 
 3.3 Results and discussion 
 3.3.1 Choice of the catalyst 
One of the biggest challenges in designing a functional halogen-bond based catalyst is 
having a suitable backbone with an activated halogen atom which has the capability to form a 
strong halogen-bond. In our previous studies we found that the iodo ethynyl group has a potential 
to form strong halogen-bonds with nitrogen based acceptor groups and halide anions (Figure 3-
11). 
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Figure 3-11 Examples of iodo ethynyl group acting as a halogen-bond donor (top) with Br- 
ion (bottom) with nitrogen and iodine acceptor groups 
 
 In order to combine two iodo-ethynyl fragments, we used Schiff-base approach on a 1,2-
diaminocyclohexane backbone. This molecule may form a chelate or due to the flexible nature of 
the bonds, the molecule may also act as a “bridge” between two anions. (Figure 3-12)  
 
 
 
 
 
 
Figure 3-12 Two possible arrangements of L1 with bromide anions 
 
  3.3.2 Choice of the reaction 
Huber and co-workers established that Ritter-type solvolysis of benzhydryl bromide is an 
ideal benchmark reaction to study catalytic activity based on halide abstraction (Figure 3-13).9  
In this reaction, acetonitrile is used both as a solvent and as a nucleophile and the intermediate 
nitrilium ion reacts with the traces of water in the solvent to form N-benzhydryl acetamide. 
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Figure 3-13 Ritter-type solvolysis of benzhydryl bromide 
 
Since there are no additional reagents required, side reactions are not observed and this 
provides an ideal environment to study halogen-bond based catalysis. However, during the 
reaction, weakening of the C-Br bond can take place as a result of a C-I---Br halogen bond and 
in an extreme situation this may lead to a heterolytic cleavage. An additional driving force may 
arise by the insolubility of the halogen-bond complex formed between the halogen-bond donor 
and the halide anion (Figure 3.14). Therefore, there is a possibility that the halogen-bond donor 
(catalyst) might not be available for further substrate activity and thus stoichiometric amounts of 
catalyst might be required. 
 
 
 
 
 
 
Figure 3-14 Halide abstraction and complex formation with the catalyst during the reaction 
 
 3.3.3 Analysis of the catalytic activity  
Product formation was determined using 1HNMR spectroscopy by measuring the ratio of 
the product peak (literature value appears around 6.15-6.30 ppm) to the peak of the starting 
65 
material, (singlet at 6.45 ppm), however based on the coordination with activating agent or H+ 
position of the peak can be varied,14, 15 and in our experiment a new peak appeared around 5.77 
ppm. No product was formed without any catalyst even after 96 hrs (Figure 3-15). 
 
 
 
 
 
 
 
 
 
 
 
Figure 3-15 1 HNMR spectrum of the reaction without any catalyst after 96 hrs 
 
According to the 1H NMR spectra the addition of L1 (100% loading) resulted in 90 % 
conversion of starting material to the product after 96 hrs. No side products or decomposition 
products of L1 were appeared in the NMR spectra. When 10 % of L1 was added, the product 
conversion was 33 % and with 20% addition this was increased to 63 % conversion. This 
observation confirms the stoichiometric effect of the catalyst during the reaction progress.  
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Figure 3-16 Reaction progress with different catalytic loading 
  
Analysis of the catalytic activity in different time intervals showed that activity reached 
its maximum after 96 hrs (Table 3-1 and Figure 3-17). Therefore the optimum conditions for the 
catalytic system are; stoichiometric amount of catalyst loading and 96 hr reaction time.  
Table 3-1 Reaction progress over the time with changes of the catalytic amount 
Amount of L1                                                          1HNMR yields 
24 h 48 h 96 h 
10 % 21.6 % 32.5 % 33 % 
20 % 25.6 % 38.3 % 63 % 
100 % 33 % 66 % 90 % 
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Figure 3-17 Reaction progress of L1 with change of time; with 100 % loading, blue circles 
represents the changes of the starting material and the red circle shows the product 
formation 
 During the reaction progress, we noticed a precipitate formation and we suspect that 
halogen-bond donor might not be available for further reactivity. This assumption was further 
supported by the disappearance of 1HNMR peaks in the product spectrum and analysis of the 
precipitate confirmed the presence of the peaks associated with the catalyst (Figure 3-18). 
 
2 h 
24 h 
72 h 
96 h 
48 h 
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Figure 3-18 1HNMR spectrum of the precipitate, formed during the reaction 
 
 These results were confirmed by the repetitive experiments.  Comparative experiments 
with non-iodinated and with an un halogen-bond donor respectively were carried out to confirm 
that source of the catalytic activity is halogen bonding. In using L1-phenyl as a catalyst after 96 
hrs with loading a stoichiometric amount we found < 5% product formation and appearance of 
additional peaks in the 1HNMR spectrum (Figure 3.19). Similar observation was seen with L1-
Chloro. The appearance of additional peaks suggests that both L1-phenyl and L1-chloro 
decompose during the reaction and have no effect to the catalytic activity (Figure 3-19). 
 
 
 
 
 
 
Figure 3-19 Appearance of additional peaks in the NMR spectrum of L1-Chloro after the 
reaction 
mp-p3-ca-l2-chlor-4d-final
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In theory if acetonitrile get hydrolyzed in the presence of L1, it could generate acetamide 
and over the time it could react with benzhydryl bromide. This hypothesis was ruled out by 
analyzing L1 in acetonitrile for several days; acetamide was not detected. Since we used a Schiff 
base approach to synthesize catalyst molecules we could not use acids as a control to rule out any 
hidden acid catalysis in the reaction (imine bonds are susceptible for hydrolysis). But in a 
previous study Huber and his co-workers has used 5 % of HOTf for Ritter-type solvolysis of 
benzhydryl bromide and confirmed that there is a very little effect (< 25 % yield) of acid and 
catalytic activity can be atributed to halogen bonding. In the same study they confirmed that the 
HBr generated during the reaction is not active in an autocatalytic way.14 Consequently we can 
state that the results obtained with L1 are strongly indicative of a halogen-bond donor as a 
catalyst.  
 3.4 Conclusion 
In this study, we introduced a iodo ethynyl based halogen-bond donor molecule as a 
catalyst and successfully used it in a bench mark Ritter-type solvolysis reaction. Control studies 
effectively ruled out the hidden catalysis based on the presence of other functional groups and 
confirmed the catalytic activity is based on halogen bonding.  The optimum conditions for the 
catalytic system were; a stoichiometric amount for 96 hrs. Through this study we were able to 
add another proof to the limited pool of halogen based catalysts and in future we will analyze the 
activity and modify our catalyst for different reactions to obtain better results.  
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Chapter 4 - Usage of structural mimics in exploring structural 
landscapes of poorly soluble molecular solids: An insight for future 
API-co-crystallization 
 4.1 Introduction 
 4.1.1 Importance of co-crystallization 
Pharmaceuticals generally comprise of an active pharmaceutical ingredient (API), a 
formulation containing an inactive material as a carrier system, and a package for market 
performance and appeal.1Crystalline API’s are strongly preferred due to the ease of isolation, and 
physio-chemical stability that the crystalline solid state affords.2 However, designing new active 
pharmaceutical ingredients (API) in their crystalline forms is often challenging due to poor 
solubility2 of API as it limits adsorption and bioavailability in vivo.3 Many drug candidates do 
not reach the market due to poor solubility and therefore this is a key parameter that needs to be 
addressed at several stages of drug discovery and formulation.4 According to the 
Biopharmaceutical classification system (BCS) APIs can be divided into four main classes:5 
Class 1, drug candidates that have good solubility and good permeability; Class II, drugs that 
have good membrane permeability but poor solubility; Class III, molecules with high solubility 
but poor permeability. Class IV drugs are poorly soluble as well as poorly permeable through the 
membrane (Figure 4-1). Class III and class IV drugs often fail to reach the final stage of drug 
discovery due to poor optimum properties.5 
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Figure 4-1 BCS classification of API’s 
 
 Crystalline forms of API’s are primarily limited to salts, polymorphs and 
solvates, however crystal engineering affords another prototype for the development of a fourth 
class of APIs called pharmaceutical co-crystals.2 In 2016, the FDA released their guidance on co-
crystal classification which indicates that co-crystals, along with salts and polymorphs, are likely 
to play important roles in future discussions and developments of new APIs.6 “Co-crystals are 
considered as crystalline materials composed of two or more molecules in the same crystal 
lattice”7 and in the definition of pharmaceutical co-crystals8 one component in the crystal lattice 
is the therapeutic agent (Figure 4-2). Co-crystals are formed through non-covalent interactions 
which does not involve any breaking or making covalent bonds, 9 and this technique can 
therefore be used to fine-tune physical properties of API through precise control over molecular 
assembly without affecting the therapeutic activity.10  
 
 
 
 
 
Figure 4-2 Co-crystal formation between an API and a co-former via non-covalent 
interactions 
Class 1 
High solubility and 
high permeability 
Class II 
Low solubility and 
high permeability 
Class III 
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A typical co-crystal screen is often carried out via liquid-assisted grinding11 followed by 
an analysis of the resulting solid using infra-red,12 Raman spectroscopy13 or X-ray powder 
diffraction.13 Although these methods can determine if a new solid form has been obtained, a 
more detailed picture of how the two components interact with one another requires that the 
crystal structure of the new solid be solved. Unfortunately, effective crystal growth of co-crystals 
composed of a poorly soluble API and a more soluble co-former can be very challenging due to 
the tendency of precipitation of the less soluble substance as a homogenous solid, thus leaving 
the co-former behind in solution. Consequently, it can be very difficult to obtain enough 
information about the structural landscape that surrounds a particular target, which will hamper 
the development of robust and practical guidelines for co-crystal synthesis of high-value 
compounds. 
 4.1.2 Importance of structural mimics 
   In order to overcome the problems outlined in 4.1.1, we decided to explore the use of 
‘structural mimics’ as a way of extracting key information which allows us to indirectly 
construct the structural landscape of a molecule of interest. A suitable ‘structural mimic’ should 
carry the same primary functional groups as the target which provides the ability to form the 
same primary intermolecular interactions as those displayed by the target. In addition, the mimic 
would not need to carry chemical functionalities that caused the molecule to be so poorly soluble 
since those fragments are unlikely to play key role in co-crystal formation (although they are of 
course critical for its biological activity). The dominant structural features of the pure drug also 
need to be preserved in the crystal structure of the mimic itself in order for it to be considered as 
an appropriate ‘structural mimic’. Non–covalent interactions formed by mimic molecule can then 
be easily compared to the actual drug by preserving the main functional groups in both 
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molecules. In crystal engineering it has been shown that functional groups of different molecules 
behave comparably when similar environmental conditions are provided.14 Therefore we may 
use the concept of “structural mimics” to map out binding preferences and to modulate physical 
properties of poorly soluble API’s. 
  4.1.3 Choice of API for the study 
  Erlotinib sold as a hydrochloride salt under the brand name Tarceva,15 was selected as the 
target molecule in this study. Erlotinib is used to treat non-small cell lung cancer, pancreatic 
cancer and several other types of cancer and is known as a tyrosine kinase inhibitor.15 Erlotinib 
hydrochloride has its maximum aqueous solubility (≈ 0.4 mg/ml) at a pH of approximately 2  but 
as this drug is administered in an acidic form it is not an ideal drug candidate for cancer patients 
with gastrointestinal issues.16 There are nine entries in the CSD of erlotinib related structures, 
seven of them are salts or hydrates, and there is only one genuine co-crystal (with urea as the co-
former).17  Interestingly, according to Desiraju and co-workers the native drug has a tendency to 
convert to its monohydrate during co-crystallizations which adds an element of uncertainty to the 
preparation of new solid forms of erlotinib.17 Therefore we decided to synthesize a structural 
mimic of erlotinib in order to make co-crystals thereof that could offer more information about 
the structural landscape of the native substance itself.   
Erlotinib has two heterocyclic nitrogen atoms that can act as hydrogen-bond acceptors, and one 
N-H and one ethynyl proton both of which can act as hydrogen-bond donors, (Figure 4-3) As 
these functional groups are likely to play important roles in the primary intermolecular 
interactions in the native drug, we wanted to preserve these four recognition sites (and their 
relative orientation) in the mimic. The remaining alkyl groups (which lower the aqueous 
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solubility) were discarded as they were not thought to be important drivers for co-crystal 
formation.    
 
 
 
 
 
Figure 4-3 Potential acceptor (red) and donor moieties (blue) in erlotinib (left), and of its 
structural mimic (right) 
 
 4.1.4 Goals of the study 
Goals of this study are,  
1) To synthesize a structural mimic to erlotinib 
2) To carry co-crystallization experiments of the mimic with water soluble dicarboxylic 
acids 
3) To analyse the crystal structures of the mimic to identify main interactions 
4) To examine the aqueous solubilty of new solid forms to correlate molecular properties of 
co-former to dial-in physical properties of co-crystals 
5) To correlate the structural behaviour of  the mimic with the actual drug molecule  
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 4.2 Experimental 
4-Chloro-6, 7-dimethoxyquinazoline and 3-ethynylaniline was purchased directly from 
Alfa Aesar and used without further purification. Other reagents and co-formers were purchased 
from available commercial sources and utilized without further purification. Melting points were 
measured using Fisher-Johns melting point apparatus. 1H NMR was reported using a Varian 
Unity plus 400 MHz spectrophotometer in CDCl3. IR Spectroscopy was carried out on a Nicolet 
380 FT-IR. PXRD was taken on Rigaku miniflex 600 and UV measurements were taken on 
Shimadzu UV-1650 PC. 
 4.2.1 Synthesis of N-(3-ethynylphenyl)-6-7-dimethoxyquinazolin-4-amine(A1)18, 19 
 
 
 
 
 
 
4-Chloro-6,7-dimethoxyquinazoline (200 mg, 0.89 mmol) and 3-ethynylaniline (0.13 g, 
1.6 mmol) were mixed and refluxed in 25 ml of 2-propanol for 1h. Resulting white solid was 
filtered and dissolved in 50 ml of methanol. Solution was basified with sat. NaHCO3 and 
extracted in to chloroform. A slightly brownish solid was obtained after concentration. (70% 
yield). M.p: 275-280oC. (Lit. 290-292oC)19 (1HNMR, DMSO-d6 δ H) 8.68( s 1H) 7.80 (s 1H) 
7.29 (t 1H) 7.26 (t 1H) 7.22 (s 1H) 6.97 (s 1H) 5.29 (s 1H) 3.96 (d 6 H) 3.07 (s 1H)  
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 4.2.2 Molecular electrostatic potential calculations 
Molecular electrostatic potential surfaces for erlotinib and A1 were obtained via density 
functional theory (B3LYP) using 6-31G* basis set in vacuum. All calculations were carried out 
using the Spartan’08 software. 
 4.2.3 Synthesis of co-crystals and salts of A1 
A1 (10 mg) and the co-former (succinic acid, adipic acid, suberic acid, sebacic acid and 
dodecanedioic acid respectively) were mixed in 2:1 ratio and ground on a spotting plate with the 
help of a drop of methanol. The ground mixture was then analyzed via IR spectroscopy for initial 
screening. Co-crystal formation was demonstrated by the appearance of two broad bands 
indicative of O-H...N hydrogen bonds at around 1850-2450 cm-1 20, and of significant shifts of 
the carbonyl stretch of di-acids around 1650-1700 cm-1. Four of the five experiments produced a 
co-crystal, only the combination with sebacic acid failed to produce the targeted multi 
component solid. We subsequently attempted to grow crystals suitable for single-crystal X-ray 
diffraction of all five ground mixtures. Suitable crystals were obtained for the four co-crystals 
but only homomeric solids (recrystallizations) were produced in the combination of A1 and 
sebasic acid. Since the erlotinib is administered as the hydrochloride salt, to understand the 
behavior of our mimic in the salt form, the hydrochloride salt of the A1 was also synthesized and 
analyzed via X-ray crystallography. 
 4.2.3.1 Synthesis of N-(3-ethynylphenyl)-6-7-dimethoxyquinazolin-4-aminechloride 
A1H+:Cl- 
4-Chloro-6,7-dimethoxyquinazoline (100 mg, 0.44 mmol) and 3-ethynylaniline (0.063 g, 
0.80 mmol) were mixed and refluxed in 12.5 ml of 2-propanol for 1h. The resulting white solid 
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was filtered and recrystallized in water: methanol (1:1) mixture. (M.p: 255-260oC) (Lit: 269-
270oC)18 
 4.2.3.2 Synthesis of di-N-(3-ethynylphenyl)-6-7-dimethoxyquinazolin-4-aminesuccinic 
acid (A)2:SUC)  
A1 (10 mg) was mixed with 2 mg of succinic acid and  dissolved in 4 mL of 
methylenechloride and ethyl acetate mixture in a 2 dram borosilicate vial at room temperature. 
The mixture was allowed to slow evaporate and colorless block crystals were obtained within 
one week. 
4.2.3.3 Synthesis N-(3-ethynylphenyl)-6-7-dimethoxyquinazolin-4-amineadipate 
(A1H)2
+:ADP-:ADP.MeOH) 
Adipic acid (2.4 mg) was mixed with 10 mg of A1 and dissolved in 2 ml of methanol in a 
2-dram borosilicate vial. After letting the solution to slow evaporate colorless block crystals were 
obtained within two weeks. 
 4.2.3.4 Synthesis of di-N-(3-ethynylphenyl)-6-7-dimethoxyquinazolin-4-aminesuberic 
acid (A12:SUB) 
To A1(10 mg), 2.8mg of suberic acid was added and dissolved in methanol in a 2 dram 
borosilicate vial at room temperature. After slow evaporation of the solvent block colorless 
crystals were obtained within one week   
  4.2.3.5 Synthesis of di- N-(3-ethynylphenyl)-6-7-dimethoxyquinazolin-4-
aminedodecanedioic acid (A12:DOD) 
To A1 (10 mg), 3.7 mg of dodecanedioic acid was added and dissolved in 
methylenechloride in a 2-dram borosilicate vial at room temperature. After slow evaporation of 
the solvent block colorless crystals were obtained within one week. 
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Table 4-1 Melting points of the crystals and solvents used in crystallization experiments 
  
 4.2.4 Solubility studies 
 4.2.4.1 Large scale synthesis of co-crystals  
Large scale synthesis of co-crystals for solubility studies were done via solvothermal 
method.21 Supersaturation of A1 and succinic acid was done by refluxing a mixture of succinic 
acid (90 mg, 0.82 mmol) and A1 (0.50 g, 1.63 mmol) in 30 ml of methanol for 20 min. 
Immediate cooling to 0oC resulted in a solid formation. The solid was filtered and dried. Co-
crystals of A1 and dodecanedioic acid and suberic acid were prepared by following the same 
procedure. Solids were analyzed via IR spectroscopy and PXRD to confirm the formation of co-
crystals and the homogeneity of the crystals.  
 4.2.4.2 Solubility measurement of A1 
Equilibrium solubility of A1 was determined via a gravimetric method. A saturated 
solution of A1 was prepared by dissolving 0.12 g of A1 in 10 mL of distilled water at room 
temperature. The vial was sealed and sonicated for 5 min to break any lump and stirred in a 
water bath. After stirring for 12 hrs at room temperature, the remaining solid was filtered and 
dried. Solubility was measured by the difference of initial and final weight of A1. The 
Co-crystal/salt Melting point (0C) Solvents used 
A1H+:Cl-  255-260 Methanol/Water 
(A1)2: SUC 210-215 Methylenechloride/Ethylacetate 
(A1H)2
+: ADP-:ADP.MeOH 175-180 Methanol 
(A1)2: SUB 190-195 Methanol 
(A1)2: DOD 185-190 Methylenechloride 
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experiment was carried out for 24 h, 48 h and 72 h to obtain the equilibrium solubility. After 
determining the optimum time period for the equilibrium solubility, a stock solution of A1 was 
subjected to serial dilutions and their corresponding absorbance was recorded at 223 nm and 
plotted against concentration of A1. The equation of the line was used to determine the unknown 
concentrations of A1 during co-crystallization experiments 
 4.2.4.3 Solubility measurement of co-crystals 
A suspension of the co-crystal (0.5g) was dissolved in 10 ml of distilled water in a sealed 
vial and placed in a water bath to maintain a constant temperature. After stirring for 48 hrs, the 
remaining solid was filtered off. Absorbance of the resulting solution was measured at 223 nm 
using UV-Visible spectroscopy and required dilutions were carried out to obtain a suitable 
absorbance value. The absorbance values (y values) were used to calculate the corresponding 
concentrations (x) from the equation of line (y=mx+c) of the calibration curves. The calculated 
concentrations were multiplied by the dilution factor to obtain the actual concentration and thus 
the solubility of the co-crystals. 
 4.3 Results and discussion 
 4.3.1 Electrostatic potential value comparison of erlotinib and A1 
   It has been reported that electrostatic potential calculations on molecules with multiple 
acceptors and donors provide pathways for predicting binding preference in co-crystallization 
experiments,22, 23 and in order to find and compare the binding preference of erlotinib and A1 
electrostatic potential values were calculated. Based on the electrostatic potential calculation,  the 
sterically unhindered pyrimidyl nitrogen atom in both A1 and erlotinib showed the highest 
negative electrostatic potential value and since the difference between calculated electrostatic 
potential values on other acceptor sites on A1 and erlotinib are greater than 38 kJ/mol, the 
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sterically unhindered nitrogen atom can be considered as the best site for molecular recognition 
events.23 Similarly, among the donor moieties the amine NH group in both A1 and erlotinib 
showed the highest positive potential value and was regarded as the best site as a donor group. 
These results confirm that even with the changes in the length of the side chain in A1, the 
calculated electrostatic potential values are comparable with the erlotinib. (Figure 4-4) 
 
  
 
 
 
 
 
 
 
 Figure 4-4 Calculated molecular electrostatic potential values on acceptor (red) and 
donor (blue) atoms on A1 (right) and erlotinib (left) 
 
 4.3.2 IR and PXRD data analysis of co-crystals 
Analysis of A1 with di-acids was initially carried out through IR spectroscopy. IR 
spectroscopy provides very reliable predictions for non-covalent interactions comparing the 
changes in the spectrum of co-crystals with the spectrums of the co-formers. Since we used 
carboxylic acids as donors, changes of the main functional groups are used to indicate positive 
results for co-crystal formation. With A1 carboxylic acids could form O-H---N hydrogen-bond 
interaction and C=O----H-N interaction. The O-H---N hydrogen-bond interaction is mainly 
identified through a characteristic double hump which appeared in the 1800 cm-1-2300 cm-1 
region. N-H interaction with the carbonyl oxygen group can be easily identified through changes 
of the carbonyl stretch which usually appears in the 1650-1700 cm-1 region. Figure 4-5 shows 
one example of an IR spectrum of N-H---O interactions through double humps and shifts of the 
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carbonyl stretch due to C=O---H-N bond formation. Based In this study positive results were 
observed with succinic acid, adipic acid, suberic acid and dodecanedioic acid, but not with 
sebacic acid.  
 
Figure 4-5 Positive results showing co-crystal formation through double humps (green 
circle) and carbonyl peak shift (red circle) on the IR spectrum 
 
IR analysis was again used in initial screening of large scale co-crystal synthesis through 
the solvothermal method. In this method, the IR spectrum of the resulting solid was compared 
with the IR spectrum of the crystalline form of the co-crystal. Figure 4-6 shows two overlaid d 
IR spectrums of (A1)2:SUC. 
 
 
 Co-crystal 
A1 
Suberic acid 
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Figure 4-6 Comparison of the IR spectrums of the co-crystal of succinic acid (purple) and 
the solid obtained through solvothermal method (red). 
 
Even though IR analysis is helpful for the initial screening of co-crystal formation; it does 
not provide any evidence of homogeneity of the co-crystal solids which is essential when 
carrying out the solubility experiments. In order to clarify the co-crystal formation through 
solvothermal methods a PXRD analysis was carried out. Having an excess of the highly soluble 
acid will provide inaccurate data in solubility studies. PXRD of the analyzed co-crystals 
(generated through Mercury software) was compared with the PXRD data of the co-crystal solids 
obtained through the solvothermal method. Having a matching spectrum, without any other extra 
peaks confirms the homogeneity of the co-crystal solids. Figure 4-7 shows a comparison of the 
stimulated and experimental powder pattern of (A1)2:DOD. 
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Figure 4-7 Stimulated (black) and experimental (Red) (solvothermal) powder pattern of 
(A1)2:DOD  
 4.3.3 Structural outcomes of A1 with co-formers 
 4.3.3.1 Crystal structure of hydrochloride salts of erlotinib and A1 
Since erlotinib is given in the form of hydrochloride salt we initially compared the crystal 
structure of the hydrochloride salt of the mimic with that of the structure of the chloride salt of 
erlotinib. In both cases, the proton is transferred to the less sterically hindered pyrimidine 
nitrogen atom (which has the largest negative electrostatic potential). (Figure 4-8) The primary 
hydrogen bonds in both structures are N-H (amine)---Cl- and N-H+(pym)---Cl- hydrogen bonds 
and in both cases the supramolecular outcome is a hydrogen bonded 1-D architecture. The 
hydrogen bond distances and bond angles are very similar in both structures. Bond distance and 
angle of N-H+---Cl- is 3.066(2) Å and 169(2)o for erlotinib and 3.0681(17) Å and 165o for A1 
respectively. Similarly erlotinib and A1 had N-H---Cl- bond distance and angle of 3.277(2) Å 
and 167(2)o, 3.2121(17)Å and 160o, respectively. Considering these main structural similarities, 
we conclude that A1 is an appropriate structural mimic of the native drug, despite the fact that 
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adjacent molecules within each structure are related by translation and two-fold screw axis, 
respectively.  
 
 
Figure 4-8 Primary interactions in the crystal structure of erlotinib hydrochloride (top) 
and in the crystal structure of A1H+:Cl- (bottom)  
 
 4.3.3.2 Crystal structure of (A1)2:SUC 
The co-crystal of A1 and succinic acid was obtained in a 2:1 ratio.  The unhindered 
pyrimidyl N atom formed an N---H-O hydrogen-bond interaction with a O----N bond distance of 
2.618(2) Å and 174(3)o O-H---N bond angle. The secondary amine N-H formed an N-H---O 
short interaction with the carbonyl oxygen atom with N---O bond distance of 3.170(3) Å and N-
H---O bond angle of 158.5(19)o extending the structure into a 1-D chain (Figure 4-9. These 
chains were further extended to a 2-D network via π-π interactions between aromatic rings and 
the ethynyl (HC≡C–) group of two adjacent A1 molecules (Figure 4-10). 
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Figure 4-9 Primary O-H—N hydrogen-bond interaction and N-H---O short contacts in 
(A1)2: SUC crystal structure 
 
Figure 4-10 Extended 2-D network of (A1)2: Succinic acid governed by π-π interactions 
between aromatic rings and the ethynyl (HC≡C–) group 
 4.3.3.3 Crystal structure of (A1)2:SUB 
  The crystal structure showed a 1:2 stoichiometry between suberic acid and A1 (Figure 4-
11). Similar to the (A1)2:SUC co-crystal, the sterically unhindered pyrimidyl N atom formed O-
H---N interactions d(O---N) 2.584(3)Å and (O-H---N) angle 174(3)o.  The amine N-H group 
formed a N-H---O interaction with d(N---O) 2.804(3) Å and N-H---O angle 168(2)o. This 
arrangement leads to an extended 1-D architecture with repeating nodes of R44(20) tetramer 
(Figure 4-11 and 4-12). 
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Figure 4-11 O-H---N and N-H---O hydrogen- bond interaction between A1 and suberic acid 
which leads to a tetramer formation 
 
Figure 4-12 Extended 1-D network of (A1)2:SUB  with repeating tetramer nodes. 
 
 4.3.3.4 Crystal structure of (A1)2:DOD 
  The crystal structure with dodecanedioic acid showed a 1:2 stoichiometry with the acid 
and A1 molecule. With close similarity to the crystal structure of (EM)2:SUB, an R44(20) 
tetramer was formed between the pyrimidyl N, the carboxylic acid group the and amine N-H 
moiety.The  O-H----N hydrogen bond was formed with O---N distance of 2.592(3) Å and O-H---
-N angle of 177(4)o and N-H---O interaction with N----O distance of 2.999(3) Å and N-H---O 
angle of 160(3)o and these interactions give rise to infinite 1-D chains (Figure 4-13). Adjacent 1-
D chains were interconnected via C-H---π and π-π interactions (Figure 4-14). Again, the best 
hydrogen-bond acceptor on A1 was the preferred binding site for the carboxylic acid O-H 
moiety.  
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Figure 4-13 Hydrogen bonds formed by dodecanedioic acid with sterically unhindered N 
and amine NH moiety in the (A1)2:DOD co-crystal 
 
 
Figure 4-14 Extended 2-D network governed by C-H---Π and Π-Π interactions in 
(A1)2:DOD crystal structure  
 
 4.3.3.5 Crystal packing of (A1H+)2:ADP-:ADP.MeOH  
The crystal structure of A1 with adipic acid was different compared to the previous three 
co-crystal structures. We observed proton transfer to the unhindered pyrimidyl N forming N-H+--
--O-C ionic interaction. In the asymmetric unit, we observed the presence of two conformations 
of A1 (anti) (A) and syn (B) arrangement with respect to the position of amine NH group (due to 
the rotation of N-(3-ethynyl) moiety) (Figure 4-15). 
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Figure 4-15 Two conformations of A1 ( A: anti , B: syn) formed due the flexibility of  N-(3-
ethynyl) moiety 
 
In the crystal structure, adipate anion showed a difference in forming hydrogen-bond 
interactions. One carboxyl end of the acid formed N-H+-----O-C interactions with A1 molecule 
(syn) which extended 1-D along the b axis. (N---O bond length 2.717(4)Å and N-H---O angle 
175(4)o). The carbonyl oxygen group from adipate anion forms another C=O---H-O hydrogen- 
bond interaction with a free adipic acid creating a 2-D network (O---O bond distance 2.592(4) Å 
and O-H---O angle 170(5)o). From the other carboxylate end, the carbonyl oxygen atom forms a 
C=O---H-O interaction (O---O bond distance 2.770(4) Å and O-H---O angle 148(4)o) with 
solvent methanol and a C=O---N-H interaction (N---O bond length 2.908(4) Å and N-H---O 
angle 164(3)o) with NH amine group of A1 (syn). Also the N-H+ pyrimidyl group of A1 (anti) 
formed a N-H+-----O-C interaction with N---O bond length 2.599(4) Å and N-H---O angle of 
164(3)o.  The N-H amine group in A1 (anti) formed a N-H---O interaction to free adipic acid 
with N---O bond length of 2.863(4) Å and N-H---O angle of 159(3)o (Figure 4-16).  
 
A B 
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Figure 4-16 Difference in hydrogen-bond interactions with respect to the conformation of 
A1 and ADP/ADP- acids. 
 
 4.3.4 Solubility studies of A1 and co-crystals 
The solubility of A1 and its respective co-crystals were measured using an undersaturated 
solution. Equilibrium solubility of A1 was measured in different time intervals to obtain the 
maximum solubility (12 h, 24 h, 48 h, and 72 h). Based on the solubility data maximum 
solubility was obtained after 48 h of stirring in a water bath at room temperature (Table 4-2). 
Table 4-2 Concentration of A1 as a function of time  
Time  Solubility (mg/mL) 
12 h 0.11 
24 h 0.12 
48 h 0.19 
72 h 0.17 
 
Data obtained after 48 hrs is used for the standard calibration curve which was determined using 
UV-Vis spectrometry at 223 nm to determine unknown concentrations of A1 (Figure 4-17). 
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Figure 4-17 Absorbance vs the concentration of A1 
 
After obtaining the equation of line using the calibration curve, data was used to calculate the 
concentrations (solubility) of co-crystals. Since the dissolution reached eqilibrium after 48 hrs, 
solubility measurements of co-crystals also were carried out for 48 hrs. Table 4-3 shows the 
solubility data of co-crystals and Figure 4-18 shows the bar graph which highlights the changes 
of solubility with respect to type of the co-former used. 
Table 4-3 Solubility data of A1 and its co-crystals after 48 h 
Compound Solubility (mg/mL) 
A1 0.19 
(A1)2:SUC 3.60 
(A1H+)2:ADP-:ADP.MeOH 2.15 
(A1)2:SUB 1.05 
(A1)2:DOD 1.27 
. 
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 Figure 4-18 Aqueous equilibrium solubility of A1 and the co-crystals of A1 
  
Based on the solubility data it indicates that the solubility of the co-crystals of A1 is 
increased with compared to the solubility of A1. (A1)2:SUC showed 20 fold increases in the 
solubility and (A1)2:SUB and dodecanedioic co-crystals showed ~ ten fold increase in the 
solubility. However even though (A1H+)2:ADP-:ADP.MeOH showed the highest solubility we 
were not too surprised by the data since we expect  to have increase of solubility of 
salts/solvates. This data might be subjected to change with the changes of solvent molecules in 
the crystal structure of (A1H+)2:ADP
-:ADP.MeOH. However, solubility data of co-crystals are 
more reliable since the structural outcomes are not subjected to change in the presence of similar 
experimental conditions. Our results indicate the potential of co-crystallization as a tool for 
modifying the solubility of an organic molecular solid.  
 4.3.5 Correlation between and melting point of co-crystals and the melting point of 
the co-former 
The melting point is considered as an important physical property in pharmaceutical 
industry. Generally, the solubility equation is used in pharmacy to determine the aqueous 
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solubility of solutes. The melting point and partition co-efficients of solutes are the main two 
factors taken in to account in the equation. For single component systems it is straightforward to 
make predictions whereas in literature very little information is found in correlating melting 
points of co-crystals with co-formers used. With this in mind the thermal behavior of the co-
crystals with relation to the corresponding diacids were measured to observe any correlation 
between the melting points and co-formers. The data showed that the melting points of the three 
co-crystals are directly related to the melting points of the corresponding dicarboxylic acid. The 
highest melting co-crystal contains the dicarboxylic acid with the highest melting point and the 
lowest melting point was observed with lowest melting dicarboxylic acid. (Melting point of the 
A1:adipate salt showed no relation to the melting point of the acid or A1) (Figure 4-19). 
Therefore, these data suggests that by modulating the properties of the components in a co-
crystal solid we can easily regulate the properties of molecular solids.  
 
 Figure 4-19 Melting points of co-crystals (Y) vs the melting points of corresponding 
di acids (X) 
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  4.4 Conclusion  
In this study, we use the concept of structural mimics to indirectly examine the structural 
landscape of poorly soluble solids. A structural mimic to erlotinib (A1) was synthesized 
maintaining all the binding sites which are important in constructing structural landscapes. Initial 
electrostatic potential calculations of the mimic and the erlotinib showed that the sterically 
unhindered pyrimidyl nitrogen and the amine N-H moiety in both molecules have the highest 
potential to participate in non-covalent interactions. This observation revealed that even with the 
structural changes we made to the mimic it was able to maintain the binding potentials of both 
acceptors and donors and has very good structural similarity to the actual drug erlotinib. Out of 
five crystallization experiments with highly soluble, even-chain dicarboxylic acids, three 
produced co-crystals whereas sebacic acid did not and adipic acid formed an (A1H)2
+: adipate 
co-crystal salt. The intermolecular interactions observed in the series of co-crystals showed 
consistency and in all the structures, the best acceptor site (the pyrimidyl nitrogen atom with the 
largest negative electrostatic potential) formed hydrogen bonds with the –O-H group of the acid 
(the best donor site). By analyzing the CSD database for erlotinib nine hits were found and with 
the comparison of the structural outcomes of the mimic it was evident that the main interactions 
present in the actual drug and the mimic can be related (Figure 4-20). 
 
 
 
 
 
Figure 4-20 Comparisons of the structural outcomes of the mimic (EM) and erlotinib 
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Solubility and thermal analysis showed that with the systematic changes of co-crystallization 
agent it is possible to make predictable changes to physical properties. This study is a good 
example which shows that usage of structural mimics will provide benefits in exploring 
structural landscapes of poorly soluble APIs and can be used to dial-in physical properties. 
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Chapter 5 - Energetic co-crystals of 5,7-dinitrobenzotriazole with 
enhanced chemical stability 
 5.1 Introduction 
 5.1.1 Background 
 Developing energetic materials with higher performance and decreased sensitivity is a 
demanding area in both military and commercial applications.1 Apart from traditional nitro- 
containing materials like TNT, RDX,2 and HMX3, studies of heterocyclic compounds as 
energetic materials have expanded due to their high positive heats of formation and 
environmental compatibility.4 Among these heterocyclic compounds, nitro-substituted 
imidazole,5 triazole,6 tetrazole7 and pyrazole8 have shown promise as potential energetic 
materials and are currently under development.9 5, 10 However, when an electron withdrawing 
nitro group is attached, a heterocyclic N-H proton can become very acidic which may cause 
problems with respect to long-term storage and handling. (Figure 5-1) One approach to obtain a 
better energetic material is to design a completely new molecule without any acidic protons, or a 
salt. However, optimizing the explosive properties like high power, low sensitivity and low 
reactivity in a finite time scale is challenging, and most of the time power and sensitivity appear 
to be contradictory in synthesis. 11 
 
 
 
 
Figure 5-1 Commonly used nitro- containing heterocycles (a) pyrazole (b) imidazole (c) 
triazole (d) tetrazole with acidic N-H protons 
 
a b c d 
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An alternative approach is to use co-crystallization technology, where a known energetic 
material can be combined with another energetic or non-energetic material via non-covalent 
interactions.12 Co-crystallization is a very beneficial technique for improving performance and 
other chemical and physical properties of energetic materials as it does not require new chemical 
synthesis. Co-crystals of TNT, HMX and CL-20 have shown the ability for fine tuning of their 
properties and performance through co-crystallization.13  However, designing novel energetic co-
crystals is still in its early stage and most of the reported examples are based on improving 
impact/friction sensitivity.14 To date, there is only one example which shows that co-
crystallization technology can be successfully used to improve chemical stability of energetic 
materials. In that study, acidic protons of EDNA were successfully suppressed by adding 
supramolecular protecting groups, and a higher chemical stability was obtained15 (Figure 5-2). 
 
 
 
 
 
 
Figure 5-2 Addition of supramolecular protecting groups to the acidic protons of EDNA to 
suppress the chemical reactivity.15 
 
 5.1.2 5,7-Dinitrobenzotriazole as an energetic material 
Among the heterocyclic nitrogen-rich energetic materials, 1, 2, 3-triazoles are promising 
candidates due to the presence of N-N, C-N bonds and ring strain.16,17 In a recent study, Klapötke 
and co-workers investigated the explosive performance and sensitivity of 5,7-
dinitrobenzotriazole (DBT), its salts and derivatives of DBT, and found them to be energetic 
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materials.18 However, the N-H protons are acidic and limit their use as effective explosive 
materials. The crystal structure of DBT by itself shows19 that the N-H protons form N-H---N 
hydrogen-bond interactions with one of the triazole nitrogen atoms in the heterocycle. However, 
this interaction is not strong enough to reduce the acidity of the molecule. Therefore, through co-
crystallization technology, molecules which are capable of forming strong N-H---N or N-H---O 
interactions may be introduced to break (Figure 5-3) this weak self-interaction, and new 
molecules with altered performance, chemical and thermal stability and sensitivity can be 
synthesized. 
 
 
 
 
Figure 5-3 DBT molecule (left) and part of the crystal structure of DBT showing N-H---N 
hydrogen bonds (right)19 
 5.1.3 Goals of the study 
In our study, we hope to answer the following questions; 
• What are the intermolecular binding preferences of DBT with different nitrogen 
and oxygen containing acceptor molecules? 
• Can we alter the performance and thermal stability of DBT by changing the 
acceptor molecule? 
• Can we improve the chemical stability by suppressing the reactivity of acidic N-H 
proton in DBT? 
In order to achieve our goals, fifteen acceptor molecules containing nitrogen and oxygen 
atoms as acceptors were selected as co-crystallizing agents (Figure 5-4). 
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Figure 5-4 Nitrogen and oxygen containing acceptors used for the co-crystallization 
experiments 
 5.2 Experimental 
Although we did not experience any problems in handling and synthesis, DBT is an 
energetic material and should be handled with extreme care. All the synthesis was performed 
inside a fume hood and used nonmetallic spatulas for measuring DBT. Kevlar gloves, lab coat 
and goggles were worn all the time. Synthesis was only performed on a small scale (~200 mg). 
Benzotriazole and co-formers were purchased via commercial sources and used without further 
purification. 1H NMR spectra were recorded on a Varian Unity plus 400 MHz spectrophotometer 
in CDCl3. IR spectra were recorded out on a Nicolet 380 FT-IR. Melting points were determined 
on a Fisher-Johns melting point apparatus. Decomposition points were measured on a DSC Q20 
and electrostatic potential calculations were carried out using Spartan 08’ software. 
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 5.2.1 Synthesis of 5,7-dinitrobenzotriazole18, 19 
 
 
 
 
 1H-Benzotriazole (100 mg, 0.830 mmol) was dissolved in 96% sulfuric acid (1.22 ml) at 
0oC and 65 % nitric acid (1.27 ml) was then added drop wise. The mixture was stirred vigorously 
for 15 min at 0oC and heated to 120oC for 48 h.  The solution was cooled and poured into 5 ml of 
crushed ice.  The precipitate was filtered and washed with cold water. A colorless solid was 
obtained in 40% yield. (M.p196oC Dec.point 2910C, reported M.p193oC19 Dec.point 291oC) 
1HNMR ( δH,400 MHZ, DMSO-d6,) δ 8.99 ( s 1 H,) 9.55 (s 1H) 9.03 (s 1H). 
 5.2.2 Synthesis of co-crystals 
 For initial co-crystal screening, acceptors which contain symmetric and asymmetric 
pyridyl nitrogen groups and N-oxides were used. (Figure 5-4) DBT and the co-formers were 
mixed according to the stoichiometric ratio and dissolved in a minimum amount of solvent and 
subjected to slow evaporation. Once suitable X-ray quality crystals were obtained IR analysis 
and DSC analysis were done to confirm co-crystal formation. IR confirmation was done by 
analyzing the presence of peaks from both co-formers and the peak shifting with respect to the 
spectrum of acceptor and donor molecules. Once the formation of co-crystal was confirmed, 
crystals were submitted for X-ray crystallography. Out of fifteen experiments, four experiments 
produced X-ray quality crystals (Table 5-1). 
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 Table 5-1 Synthesis of DBT co-crystals   
  
 5.2.3 Impact sensitivity studies20 
 Impact sensitivities of DBT, (DBT)2:A7 and (DBT)2:A11 were measured using 
impact drop testing. Tests were performed in an apparatus designed to accommodate small 
amounts of material and was calibrated against tetranitromethane (H50=38 cm). Approximately 
0.1 mg of each sample was measured in to an aluminum DSC pan and a freefalling 5 lb weight 
was used to strike the sample from different heights (Figure 5-5). Values were measured in 
centimeters and the H50 value was recorded (the height at which the material has a 50% chance 
of detonation).21 This can only be used for relative comparison only. 
 
Co-crystal Abbreviation Mole ratio Solvent and method 
DBT:Phenazine (DBT)2:A7 2:1 Ethylacetate/methanol 
Slow evaporation 
DBT:4,4-Dipyridyl (DBT)2:A2 2:1 Methanol/THF 
Slow evaporation 
DBT:1,2(Dipyridin-4-
yl)ethylene 
(DBT)2-:A5+ 2:1 Methanol 
Slow evaporation 
DBT:4-Phenylpyridine DBT:A11 1:1 Methanol 
Slow evaporation 
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Figure 5-5 Apparatus with 5 lb weight used to measure impact sensitivity of samples  
 
 5.3 Results and discussion 
 5.3.1 Analysis of co-crystals through IR spectroscopy 
DBT contains two triazole nitrogen atoms which are capable of forming hydrogen bonds 
with suitable donors like carboxylic acid or phenols and one N-H moiety which is capable of 
acting as a hydrogen bond donor in the presence of suitable acceptors. In this study, we focused 
on the triazole N-H group which leads to chemical instability. Therefore, with the acceptors we 
chose we would expect to get new N-H---N or N-H---O hydrogen- bond interactions. We did not 
perform any grinding experiment with the co-formers since DBT is an energetic material, but 
instead analyzed the solid/crystal formed after slow evaporation method through IR spectroscopy 
to confirm the co-crystal formation before submitting to X-ray crystallography. In the IR spectra, 
we mainly focused on a few prominent peaks of DBT. N-H bending appeared around 1641 cm-1 
and two bands for –NO2 stretching appeared at 1535 cm-1 and 1338 cm-1. Since the N-H group 
and the NO2 group can form hydrogen bonds we would expect to have changes in these peaks.
22 
One example of a co-crystal which reveals significant shifting of N-H bending from 1641 cm-1-
1688 cm-1 is shown in Figure 5-6. Shifting of the N-H bending suggests hydrogen-bond 
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formation between the corresponding acceptor and donor sites, little change of the nitro group 
implies that there is no significant hydrogen- bond formation between the nitro group and N-H 
protons. 
 
Figure 5-6 IR spectrum comparison of  (DBT)2:A7 with DBT and A7 (black circles indicate 
the shifting of N-H bending of DBT upon co-crystallization) 
 
Based on the IR analysis all fifteen experiments resulted in co-crystal formation. Four of them 
yielded X-ray quality crystals (Table 5-2). 
Table 5-2 IR modes of DBT and solids/crystals obtained after slow evaporation 
Compound -N-H bending (cm-1) -NO2 stretching (cm-1) Co-crystal (Y/N) 
DBT 1641 1535, 1338 - 
DBT:A1 1633 1535,1341 Y 
DBT:A2 1629 1527,1335 Y 
DBT:A3 1636 1535,1341 Y 
(DBT)2:A7 
DBT 
A7 
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DBT:A4 1629 1537,1344 Y 
DBT:A5 1611 1507,1326 Y 
DBT:A6 1636 1535,1340 Y 
DBT:A7 1635 1535,1341 Y 
DBT:A8 1651 1531,1339 Y 
DBT:A9 1649 1532,1339 Y 
DBT:A10 1635 1535,1340 Y 
DBT:A11 1634 1535,1341 Y 
DBT:A12 1654 1537,1352 Y 
DBT:A13 1632 1534,1339 Y 
DBT:A14 1650 1535,1339 Y 
DBT:A15 1628 1534,1338 Y 
  
 5.3.2 Structural analysis of the co-crystals 
Even though IR spectroscopy provides evidence for co-crystal formation, it does not 
provide details about the binding preferences of molecules in the presence of different co-
formers. However, by looking at the binding moieties of the molecule we can make predictions 
about the structural outcome using theoretical calculations. These structural predictions can then 
be validated through X-ray structural analysis.  
 5.3.2.1 Electrostatic potential calculations 
In DBT the N-H group acts as a donor site and a triazole nitrogen atom and nitro group 
act as potential acceptor sites (Figure 5-7). Based on electrostatic potential calculations of DBT 
and the acceptor molecules (A7, A2, A5 and A11) it is evident that the N-H moiety has a higher 
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binding preference for the acceptor sites of the co-formers than the acceptor sites of the DBT  by 
itself, (Table 5-3) therefore self N-H---N interactions of DBT can be broken and new N-H---N 
hydrogen bonds can be formed with the new acceptors (Figure 5-8). 
 
 
  
 
 
 
 
 
Figure 5-7 Potential acceptor/donor sites of DBT (left) and calculated electrostatic potential 
values (right) 
Table 5-3 Electrostatic potential values of the acceptors 
 
 
 
 
 
 
 
 
 
 
 
Acceptor  Calculated electrostatic potential values 
A7 -152.3 kJ/mol 
A2 -177.2 kJ/mol 
A5 -185.6 kJ/mol 
A11 -193.2 kJ/mol 
 
Donor site 
Acceptor site 
Acceptor site 
288 kJ/mol 
-102 kJ/mol -124 kJ/mol 
-100 kJ/mol 
-117 kJ/mol 
Acceptor site 
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Figure 5-8 Breakage of self-interactions of DBT and inclusion of the new acceptor 
molecules 
 
 5.3.2.2 Weak interactions of the nitro group 
Apart from the conventional strong hydrogen bonds such as N-H----N/O and O-H---N/O 
interactions, non-conventional weak interactions like C-H---O and C-H---π interactions also play 
an important role in determining crystal packing. After forming strong hydrogen bonds with 
DBT and the corresponding acceptor, the remaining weak acceptor sites of DBT (triazole 
nitrogen and nitro groups) also have a potential to form weak interactions. Having a better 
understanding of the weak interactions of the nitro group in crystal packing is also important in 
determining the structural properties of the explosive materials. By considering the position of 
the lone pairs of the oxygen atoms in the nitro group ( Figure 5-9) there are three main modes of 
intermolecular interactions of nitro groups observed; symmetric bifurcated (a), asymmetric 
bifurcated (b) and mono coordinated (c) (Figure 5-10) however, the recognition behavior of the 
nitro group is considered as a function of both intrinsic properties of the nitro group and the 
nature of the hydrogen bond donor with which it reacts.23  
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Figure 5-9 Position of the lone pairs of the oxygen atoms in the nitro group 
 
 
 
 
 
 
Figure 5-10 Three possible modes of interaction of the nitro group between N–H donor 
groups 23 
 
The availability of aromatic –C-H groups, nitro groups of DBT can form C-H---O weak 
interactions in either of the three modes, however based on the analysis of the full interaction 
maps of the nitro group with aromatic C-H groups using Mercury software several possible 
regions of C-H---O interactions were identified (Figure 5-11).  
 
 
 
 
 
Figure 5-11 Full interaction map of the nitro group which highlights the interactions with 
aromatic –CH groups. 
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Based on the analysis, aromatic C-H groups show a higher tendency to interact with the nitrogen 
atoms from above and below the plane of nitro group. However, by considering the interactions 
of the oxygen moieties the following modes can be identified (Figure 5-12). 
 
 
 
 
 
Figure 5-12 Modes of C-H----O interactions based on the full interaction maps calculation 
 
 5.3.2.3 Co-crystal of (DBT)2:A7 
The crystal structure of (DBT)2:A7 shows successful formation of N-H---N primary 
hydrogen- bond interactions with phenazine. As expected the N-H---N self- interaction in DBT is 
disrupted and a new interaction is formed. Since phenazine is a ditopic acceptor a trimer was 
formed (Figure 5-13). 
 
 
 
 
 
 Figure 5-13 Part of the crystal structure of (DBT)2:A7 which shows new N-H---N 
hydrogen-bond formation with the acidic proton 
 
Phenazine molecules were packed orthogonal to DBT and two different types of C-H—O 
intereactions were observed. The triazole nitrogen of DBT formed  two –C-H----N interactions 
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with the aromatic hydrogens of phenazine (ca.2.59Å) and DBT (ca.2.57Å) respectively. Both 
nitro groups of DBT participated in C-H---O weak interactions (3) with phenazine (ca.2.64Å) 
and DBT (ca.2.63 Å) and with the arrangement of the nitro group in close proximity two O----N 
interactions were observed with an average bond distance of  ca.2.83Å (Figure 5-14).  
 
 
 
 
 
 
 
 
Figure 5-14 Phenazine molecules were packed orthogonal to DBT (left) and C-H---O and 
C-H---N weak interactions were dominant in the structure. 
 
 5.3.2.4 Co-crystals of (DBT)2: A2 
Similar to the crystal structure of (DBT)2:A7, N-H---N hydrogen- bond formation was 
observed between DBT and A2. Since the A2 molecule is ditopic, a trimer was formed with two 
DBT molecules (Figure 5-15). 
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Figure 5-15 Successful N-H---N hydrogen bond formation with the acidic proton of DBT 
with A2 
 
 A network of weak C-H---O and C-H----N interactions were observed with the nitro and 
triazole groups respectively. The average bond distance of the C-H---O interaction is ca.2.51Å 
and that of the C-H----N interaction is ca.2.53Å. Nitro group formed six single point interactions 
with the aromatic hydrogens of A2 and DBT and the triazole nitrogen formed two interactions 
(Figure 5-16). 
 
 
 
 
 
 
 
 Figure 5-16 C-H----N interactions formed by triazole group and C-H---O 
interactions formed by nitro group   
 
  5.3.2.5 Co-crystal of DBT:A11 
Structural consistency was maintained by forming a new N-H---N hydrogen bond with DBT and 
A11. However, A11 is a monotopic acceptor and a dimer formation was observed (Figure 5-17).  
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The triazole nitrogen atoms formed two C-H---N short contacts with aromatic hydrogen atoms of 
A11 (ca.2.595Å) and the nitro group formed three C-H---O weak interactions with a bond 
distance of ca.2.604 Å (Figure 5-18). 
 
 
 
 
 
Figure 5-17 Dimer formation via N-H---N interaction with the monotopic A11 and DBT 
 
 
 
 
 
 
 
 
 
Figure 5-18 C-H----N short contacts of triazole moiety and C-H----O interactions of the 
nitro group 
 
 5.3.2.6 Crystal structure of (DBT-)2: A5+ 
Unlike previous structures, now we observed proton transfer from the DBT N-H group to 
the pyridyl moiety forming N-H+---N- charge-assisted hydrogen bonds. The crystal arrangement 
showed a trimer formation with ditopic A5 (Figure 5-19). 
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Figure 5-19 A proton transfer occurred from DBT to A5 and a N-H+---N- ionic interaction 
was formed 
  
The C-H----O weak interactions formed by the nitro group were dominant with a average bond 
distance of 2.546 Å. Unlike previous structures the C-H---N short contacts of the triazole 
nitrogens were not observed (Figure 5-20). 
 
 
 
 
 
Figure 5-20 C-H----O interactions of  the nitro groups in the crystal structure of (DBT-)2: 
A5+ 
 
Table 5-4 Hydrogen-bond parameters of co-crystals 
Co-crystal  D-H (Å) H----A( Å) D----A( Å) DH-A( o) 
(DBT)2:A7 N(3)-H(3)---N(19) 0.96 (2) 1.92 (2) 2.831 (3) 156 (3) 
(DBT)2:A2 N(18)-H(18)---N(40) 0.97 (9) 1.82 (7) 2.767 (5) 167 (6) 
(DBT+)2:A5- N(20)-H(20)---N(1) 1.052(19) 1.64 (2) 2.689 (2) 176 (3) 
DBT:A11 N(3)-H(3)---N(16) 0.96 (2) 1.85 (3) 2.786 (2) 165 (2) 
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 5.3.2.7 Analysis of the weak C-H---O interactions of the nitro group 
By analyzing the structural outcomes of DBT with different co-formers it was evident 
that the acidic N-H protons of DBT prefer to form new hydrogen bonds with strong acceptors by 
avoiding self N-H---N hydrogen-bond formation. Nitro groups formed a network of C-H---O 
interactions in all four crystal structures with a average distance of < 2.65 Å, which is in line 
with the reported bond distances of the C-H---O interaction.24 In all four crystal structures 
eighteen C-H---O interactions were observed and by considering the mode of the interaction, the 
following pattern was identified (Figure 5-21). 
 
 
 
 
 
 
 
Figure 5-21 Distribution of the C-H----O interaction in the four crystal structures 
 
Compared to the three possible modes of interactions of the nitro group (Figure 5-10) the C-H 
group prefers the mono-coordinated interaction, and among the two possible modes of C-H---O 
interactions (according to the full interaction maps calculation), there is an ~ equal distribution 
among the four crystal structures. 
 
 
 
8/18 10/18 
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 5.3.3 Explosive and thermal properties of DBT and its co-crystals 
 5.3.3.1 Analysis of the explosive properties 
The explosive properties of new compounds were calculated based on the established 
procedures.25 We observed a decrease in explosive properties of new co-crystals compared to the 
parent DBT molecule. Among the co-crystals DBT:A11 has the lowest values for density, 
detonation pressure, detonation velocity and oxygen balance. A11 is a monotopic acceptor 
molecule and there is only one energetic DBT molecule incorporated into the crystal unit, 
therefore a decrease of explosive properties can be expected (Table 5-5). 
Table 5-5 Calculated explosive properties of DBT and its co-crystals 
 
However, the overall decrease of explosive properties is mainly due to the incorporation of non-
energetic materials into crystals. In all the co-crystals decreased oxygen balance was observed 
due to the incorporation of more carbon atoms in to the system through co-formers.  
 5.3.3.2 Analysis of the thermal properties 
DBT and all the co-crystals melt before decomposition. Except for DBT:A11, melting 
points of the other co-crystals showed an increase compared to the melting point of DBT. This 
observation can be related to the presence of strong N-H---N hydrogen bonds and the amount of 
Compound Density 
(g/cm3) 
Detonation 
pressure (GPa) 
Detonation 
Velocity(km/s) 
Oxygen balance 
(%) 
DBT 1.645 22.8 7.3 -72.6 
(DBT)2:A7 1.606 15.7 6.1 -125.8 
DBT:A11 1.509 12.5 5.5 -158.2 
(DBT-)2 :A5+ 1.607 16.7 5.1 -132.4 
(DBT)2 :A2 1.653 18.0 6.5 -119.7 
118 
weak interactions present in the crystals. DBT:A11 showed the lowest melting point in this 
group and as A11 is monotopic acceptor only one strong N-H—N bond was formed, also this 
molecular system has the least amount of intermolecular C-H---O interactions among the four 
co-crystals. However, decomposition temperature of all the co-crystals showed less than 30o C 
decrease in value compared to the parent energetic material, but all the values were above 250o C 
and we could consider that co-crystallization has not affected the thermal stability of these new 
compounds (Table 5-6). 
Table 5-6 Thermal properties of DBT and its co-crystals 
 
 
 
 
 
 
 5.3.3.3 Analysis of the Impact sensitivity  
Impact sensitivity determines the material suitability as a primary and secondary 
explosive material and determines the safety for transporting and handling. Based on the 
experimental analysis DBT showed an H50 value of 132 cm and (DBT)2:A7 and DBT:A11 
showed a value higher than 144 cm (maximum limit of the apparatus). Obtaining a higher value 
than DBT in impact drop testing indicates a decrease of impact sensitivity. This observation is in 
contrast to some of the DBT derivatives and salts which showed an increase in sensitivity after 
modifications to the hydroxyl ammonium salt of DBT and diamino-5,7-dinitrobenzotriazole.  
 
 
Compound Melting point (oC) Decomposition point (oC) 
DBT 196 291 
(DBT)2:A7 221 285 
DBT:A11 175 267 
(DBT+)2 :A5- 258 263 
(DBT)2 :A2 255 262 
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 5.3.3.4 Corrosion test studies 
To observe the effect of co-crystallization on reducing the chemical reactivity of DBT, a 
corrosion test was carried out on a copper strip. A small amount of sample (~ 1-3 mg) was 
placed on a copper strip and a drop of methanol was added. Observation was taken after 1 h. 
Based on the results, DBT showed a rapid onset of corrosion on the copper strip (Figure 5-22), 
while the co-crystals of DBT showed no reaction with the copper strip (Figure 5-23 and 5-24). 
 
Figure 5-22 Corrosion test study of DBT on a copper strip results for initial (left) and 1 h 
later (right) 
 
Figure 5-23 Corrosion test study of (DBT)2 :A7 on a copper strip results for initial (left) and 
1 h later (right) 
 
Figure 5-24 Corrosion test study of co-crystal DBT:A11 on a copper strip results for initial 
(left) and 1 h later (right) 
 
 5.4 Conclusions 
          In this study, we successfully suppressed the chemical reactivity and decreased the 
sensitivity of DBT by introducing co-formers in to the system through N-H---N hydrogen bond 
formation. (Figure 5-25) Out of fifteen positive co-crystals (through IR analysis) four crystals 
were analyzed and data confirmed the consistency of hydrogen bond formation with the nitrogen 
based acceptors. With ditopic acceptors more DBT molecules were incorporated and produced 
higher thermal and explosive properties compared to the monotopic acceptors which lead to a 
significant decrease in the explosive properties. Therefore, selecting mulitopic acceptors as co-
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crystallization agents with DBT is more effective to obtain enhanced explosive and thermal 
properties. 
 
 
Figure 5-25 Outcome of the study 
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Chapter 6 - Enhancing chemical stability of energetic derivative 
tetranitrobisimidazole through co-crystallization: A solution to 
hygroscopicity and acidity issues 
 
 6.1 Introduction 
 6.1.1 Background 
One of the major problems associated with dense nitrogen containing heterocycles as 
energetic materials is the presence of acidic N-H protons which causes higher chemical reactivity 
and limits the long-term storage and handling. Hygroscopicity is often a consequence of having 
acidic N-H protons which limits the usage of energetic materials.1 Hygroscopicity is the 
tendency of a material to absorb moisture, and the introduction of water into an explosive is 
highly undesirable.2, 3 Introduction of water into a reactive material can reduce the sensitivity and 
alter the stability. For an example, ammonium dinitramide (ADN) is a relatively newly 
discovered energetic material and the smooth development of the propellants based on ADN is 
limited in the USA due to its severe hygroscopic properties. 2 Designing new energetic materials 
without acidic protons or making salts is the most common approach to reduce hygroscpoicity, 
however designing new molecules with desired performance, stability and acceptable sensitivity 
has not shown to be an easy task.4 5 To the best of our knowledge co-crystallization technology 
has not been applied to hygroscopic energetic materials. Therefore there is an urgent requirement 
to determine if this technology can replace water molecules and improve stability and properties 
of  hygroscopic energetic materials (Figure 6-1). 
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Figure 6-1 Replacement of water molecules of hygroscopic materials through co-
crystallization 
 6.1.2 TNBI as an energetic material 
4,4’,5,5’-Tetranitro-2.2’biimidazole (TNBI) is an energetic material with high thermal 
stability and a positive oxygen balance, and is referred to as a potential RDX replacement.6 
However, there are four electron withdrawing nitro groups in the molecule which makes the N-H 
protons highly acidic (Figure 6-2). For this reason, TNBI is chemically reactive and can cause 
problems for long term storage and handling. Also TNBI is hygroscopic which makes it almost 
impossible to use as an energetic material.7  
 
 
 
Figure 6-2 Structure of TNBI 
 
 The crystal structure of TNBI itself shows that two water molecules are incorporated in 
the lattice via N-H---O hydrogen bonds (Figure 6-3).8 To eliminate water we need to introduce 
molecules which are capable of forming strong hydrogen bonds with N-H protons. 
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Figure 6-3 Part of the crystal structure of TNBI showing N-H---O hydrogen bond 
formation with the water molecules8 
 
 6.1.3 Goals of the study 
In this study, we expect to answer the following questions, 
1) Can we replace water molecules in TNBI with suitable co-formers? 
2) Can we reduce the chemical reactivity and hygroscopicity of TNBI through co-
crystallization? 
3) Will the explosive and thermal properties of TNBI change by changing the co-
former? 
In order to find out the behavior of TNBI in co-crystallization experiments, fifteen 
different co-formers based on nitrogen and oxygen as acceptor moieties were selected (Figure 6-
4). 
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Figure 6-4 Acceptors used for the co-crystallization experiments with TNBI 
 6.2 Experimental  
All the chemicals including co-formers were purchased via available commercial sources 
and used without further purification. 1H NMR spectra were recorded on a Varian Unity plus 400 
MHz spectrophotometer in CDCl3. IR spectra were recorded on a Nicolet 380 FT-IR. Melting 
points were determined by Fisher-Johns melting point apparatus. Decomposition points were 
measured on a DSC Q 20 and thermo gravimetric studies were done on a TGA Q 50.TNBI is a 
potential explosive molecule. Even though no incident occurred during handling, synthesis was 
done in a small scale (~ 200 mg) and handled carefully. All the synthesis was performed inside a 
fume hood and used nonmetallic spatulas to measure TNBI. Kevlar gloves, lab coat and goggles 
were worn all the time. 
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 6.2.1 Synthesis of 2, 2’- bisimidazole (BI)6 
 
 
 
 
 
 
To a solution of sodium bisulfite (18.30 g, 175.5 mmol) in 90 ml of water, 50 ml of 
ethanol was added. Afterward 12.77 g (38 mmol) of 40 % glyoxal was added and the mixture 
was stirred for 1.5 h at ambient temperature. The white solid obtained was then filtered and 
washed with ethanol and diethyl ether. The solid was redissolved in aq. NH3(138 ml, 25%) and 
ammonium carbonate (5 g). The mixture was refluxed for 4h and cooled to room temperature. 
After filtering and washing the resulted solid with ethanol and diethylether light yellow color BI 
(1 g) was obtained in high purity. (38%) M.p > 300oC. Lit value >3000C9 (1H NMR, DMSO-d6, 
7.06 (m, 4H), 12.55 (s, 2H) 
 6.2.2 Synthesis of 4,4’,5,5’-tetranitro-2,2’-bisimidazole (TNBI)6 
 
 
 
A suspension of sodiumnitrate (1.8 g 5.7 mmol) was prepared by adding 2 mg 
(0.030mmol) of urea in 3 ml of sulfuric acid at 0oC. 2,2’-bisimidazole (0.50 g, 4.5 mmol) was 
added in small portions. Mixture was stirred at ambient temperature for 1 hour and heated to 
85oC-90oC for 16 h. Suspension was then poured into ice water (20 ml) and the resulting 
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precipitate was filtered and washed with ice water to get a yellow color product in ~48% yield. 
Dec.point 289oC. Lit. 287oC7  
 6.2.3 Synthesis of co-crystals 
Co-crystals were made with monotopic and ditopic acceptor molecules which contain 
oxygen and nitrogen as acceptor moieties. Co-formers were mixed according to the 
stoichiometry and dissolved in the minimum amount of solvent and subjected to slow 
evaporation to get suitable crystals. Among the co-formers, 4,4’-bipyridyl, trans-1,2-bis(4-
pyridyl) ethylene, pyrazine and 1,2-bis(4-pyridyl)ethane showed rapid yellow color precipitation 
upon addition of the solvents and the resulting solids had very poor solubility in common 
solvents and not further analyzed. IR and DSC analysis were performed to confirm co-crystal 
formation. Out of fifteen experiments, four X-ray quality crystals were obtained (Table 6-1). 
Table 6-1 Synthesized co-crystals of TNBI 
Co-crystal Abbreviation Mole 
ratio 
Solvents  Decomposition oC 
TNBI:phenazine TNBI:A7 1:1 Methanol 284 
TNBI:tetramethylpyrazine TNBI- :A4+ 1:1 Methanol/THF 278 
TNBI:2,2-dipyridyl-N,Ndioxide TNBI:A12 1:1 THF/acetonitrile 201 
TNBI:pyrazine-Noxide TNBI:(A14)2 1:2 THF/acetonitrile 215 
  
 6.2.4 Hygroscopicity studies 
Hygroscopicity studies were carried out by placing the co-crystals in a 75% humidity 
chamber for three weeks. 75 % humidity was generated by using a saturated solution of NaCl. 
Crystals were analyzed over time through TGA to observe the effect of hygroscopicity (Figure 6-
5). 
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 Figure 6-5 Humidity chamber used to analyze hygroscopicity of co-crystals 
 
 6.3 Results and discussion 
 6.3.1 Analysis of co-crystals  
 TNBI contains four nitro groups and two imidazole nitrogen atom which can act as 
acceptor moieties for potential donor molecules. Two N-H moieties are capable of acting as 
hydrogen-bond donors in the presence of suitable acceptors. In this study, we used different 
nitrogen and oxygen containing acceptors and with the presence of N-H donor groups in TNBI 
as we plan to replace water molecules and get new N-H----N or N-H----O hydrogen bonds 
(Figure 6.5). With the usage of strong acceptor moieties the nitro group does not have an 
opportunity to participate in primary hydrogen bonding; however it can form secondary O----N. 
C-H----O interactions.10 Principal N-H bending and –NO2 stretching peaks usually appear at 
1580-1650 cm-1 and 1500-1550 cm-1 and 1290-1372 cm-1 respectively.11 The  IR spectrum of 
TNBI showed  N-H bending at 1589 cm-1, and –NO2 stretches at 1529 cm-1and 1317 cm-1. 
Figure 6.5 shows one example of a positive co-crystal formation observed in IR spectroscopy. In 
this spectrum, we observe the shift of 1589 cm-1 to 1585 cm-1 and a shift of 1317 cm-1 to 1311 
 
75% 
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cm-1. However these shifts were not prominent in most of the mixtures and we mainly relied on 
the DSC analysis for the confirmation of co-crystal formation (Table 6-2). 
 
 
 
 
 
 
 
 
 
 
Figure 6-6 IR spectrum of a positive co-crystal which shows the presence of prominent 
peaks from both the co-formers 
 
Table 6-2 Decomposition temperatures of TNBI and its co-crystals 
Compound Decomposition 
temperature 
TNBI 289 
TNBI:A7 284 
TNBI:A12 201 
TNBI:(A14)2 215 
TNBI-:A4+ 278 
 
 
 
TNBI 
Co-crystal 
A7 
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 6.3.2 Structural analysis of the co-crystals 
TNBI is a ditopic donor and in the presence of ditopic oxygen or nitrogen based acceptor 
molecules it can lead to an infinite chain-like architecture through N-H---N or N-H---O 
hydrogen-bond formation (Figure 6-7). Even though the nitro groups may not participate in 
strong hydrogen-bond formation, the presence of four nitro groups can lead to a significant 
amount of weak interactions which is crucial to the overall crystal packing of the molecule and to 
obtain dense energetic materials.12  
 
 
Figure 6-7 1-D array of TNBI can be formed with ditopic acceptor molecules 
 
 6.3.2.1 Structural analysis of TNBI:A7 
N-H protons of TNBI successfully formed N-H---N hydrogen bonds with A7 by replacing water 
molecules. As expected 1-D infinite ladder type architecture was formed (Figure 6-8). 
 
 
 
 
 
 
Figure 6-8 Part of the crystal structure of TNBI:A7. Infinite 1-D architecture was formed 
through N-H----N interactions 
. 
  Each oxygen atom in the nitro group formed eight C-H----O weak interactions with a average 
distance of 2.610 Å (Figure 6-9). All the interactions were seen as single point interactions as 
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observed in our previous structures (Chapter 5). The nitro group also formed an O----N (π hole) 
interaction with a average distance of ca 3.03 Å and oxygen and nitrogen atoms were arranged 
orthogonal to each other. Even though this interaction is weaker than C-H---O interactions, O----
N bonds played a significant role in overall crystal packing, by arranging TNBI in a layered 
architecture (Figure 6-10). 
 
 
 
 
 
 
Figure 6-9 Part of the crystal structure of TNBI: network of C-H----O interactions (left) 
and  O----N (π-hole) interactions of nitro groups(right) 
 
 
 
 
 
 
 
Figure 6-10Part of the crystal packing of TNBI:A7 which shows the layered arrangement of 
TNBI 
 6.3.2.2 Structural analysis of TNBI-:A4+  
With A4, we observed a proton transfer from TNBI forming charge assisted N-H+-----N- 
bnds. Since A4 is a ditopic acceptor we would expect to have a proton transfer to both nitrogen 
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atoms in A4 and to obtain an extended 1-D chain. However only a one nitrogen atom got 
protonated with the formation of a R2
2(7) motif (Figure 6-11). This observation was evident with 
a CSD analysis which shows 119 hits for tetramethylpyrazine that with relatively weak acids 
mostly one site of A4 get protonated and other site remain intact.13 (protonation of both nitrogen 
was observed with strong acids such as HCl and HBr) 
 
 
 
 
 
 
Figure 6-11 A proton transfer from TNBI to A4 occurred with the formation of N-H+-----N- 
interaction.  
With methyl C-H groups in close proximity, the nitro group formed a network of eight single 
point C-H----O interactions with an average bond distance of ca.2.61Å (Figure 6-12).  
 
 
 
 
 
 
 
Figure 6-12 Short C-H---O interactions formed by the nitro group 
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 6.3.2.3 Structural analysis of TNBI:A12 
With the incorporation of an oxygen based acceptor molecule a similar structural 
behavior was observed as with nitrogen based acceptors. With ditopic A12, a 1-D infinite chain 
was observed with the formation of N-H---O hydrogen bonds with the replacement of water 
molecules. (Figure 6.13) Nitro groups formed seven C-H---O interactions with an average bond 
distance of ca.2.52Å and two types of O---N(π-hole) interactions were observed. Based on the 
close proximity of the oxygen atoms, nitro groups formed O-----N interactions (ca.2.953Å) with 
the neighboring nitro groups which were orthogonal to each other and another O----N interaction 
formed (2.955Å) with neighboring imidazole nitrogen which was perpendicular to the oxygen 
atom of the nitro group (Figure 6-14). 
 
Figure 6-13 Part of the crystal structure of TNBI:A12 with infinite 1-D chain with N-H---O 
hydrogen-bond formation 
 
 
 
 
 
 
Figure 6-14 C-H---O interactions (left) O---N interactions (right) of nitro groups in 
TNBI:A12  
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 6.3.2.3 Structural analysis of TNBI:(A14)2 
Even though we expected to have a linear 1-D chain with the formation of N-H---O 
hydrogen bonds, we observed trimer formation leading to a discrete architecture (Figure 6.15). 
The nitro group formed six single point C-H---O bonds (ca.2.579 Å) and a network of O----N 
interactions were observed with both nitrogen atoms of the nitro group (ca.2.831 Å) and the 
pyrazole nitrogen (ca.2.926Å) based on the orthogonal position of the oxygen atom (Figure 6-
16). 
 
Figure 6-15 Discrete architecture of TNBI:(A14)2 with N-H---O hydrogen bond formation 
 
 
 
 
 
 
 
 
 
Figure 6-16 C-H---O and O----N interactions of nitro group of TNBI:(A14)2  
 6.3.2.4 Analysis of the structural outcomes 
It is evident that both nitrogen and oxygen based acceptors can form primary hydrogen 
bonds with the acidic N-H protons of TNBI and replace water molecules. However, the presence 
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of four nitro groups also has played a significant role in the overall crystal packing. In all crystal 
structures, C-H---O interaction were formed as single point interactions with < 2.65Å bond 
distance was in accordance with the reported bond distances of other C-H---O interaction of the 
nitro groups.14 Out of 23 C-H---O bonds in all four crystals following distribution was observed 
(Figure 6-17). 
 
 
 
 
 
 
 
Figure 6-17 Distribution of the C-H----O interactions in TNBI co-crystals 
 
 We also observed several O----N interactions played an important role in arranging molecules in 
layered architectures. This type of interaction is referred to as a π-hole interaction.15 A π-hole is 
considered as a positive electrostatic potential on unpopulated π* orbitals which has the 
capability to interact with electron donor.16 It is typically located perpendicular to the molecular 
framework of a π system (Figure 6-18). 
 
 
 
 
 
4/23 19/23 
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Figure 6-18 Schematic representation of O----N π-hole interactions between two nitro 
groups 
 
 A π-hole nitro interaction can be considered as mode (a) interaction (Figure 6-18) between an 
oxygen atom and a nitrogen atom of the nitro group. Presence of extensive π-hole interactions in 
the crystals explains the small amount of mode (a) C-H----O interactions observed in the 
crystals. When considering the O---N interaction with the nitro groups electron densities are 
considered to be located above and below the C-N bond.15 By analyzing the electrostatic 
potential distribution of TNBI, electron deficient region was observed on the nitrogen atoms of 
the nitro group which is located above and below the molecular frame work (Figure 6-19). 
 
 
 
 
 
 
 
Figure 6-19 Electrostatic potential calculation of TNBI which shows the positive 
electrostatic potential on the nitrogen atom of the nitro group (blue)  
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In TNBI:A7 ,TNBI:(A14)2 and TNBI:A12 we observed π-hole interactions with the oxygen 
atoms of the nitro groups perpendicular to the plane of the TNBI molecule.  
 6.3.3 Calculation of the explosive properties  
Densities of the crystals were obtained from the X-ray crystallographic data and 
explosive properties detonation velocity, detonation pressure and oxygen balance was calculated 
using established procedures (Table 6-3).17  
Table 6-3 Explosive properties of TNBI and co-crystals 
 
Co-crystallization of energetic materials with non-energetic materials results in decrease of 
explosive properties, however TNBI:(A14)2 showed a crystal density closer to RDX, and higher 
detonation velocity, detonation pressure and a good oxygen balance. TNBI:A12 showed a good 
oxygen balance with a slight decrease of explosive properties. TNBI:A7 also has a 
comparatively high density with a slight decrease of explosive properties. However, TNBI-
:(A4)+ had the lowest density compared and thus lower explosive properties. Tetramethyl 
pyrazine consist of extra covalent hydrogen atoms which usually have a lower mass density than 
oxygen and nitrogen atoms, which lead to a lower crystal density.18  
 
Compound Density g/cm3 Detonation 
velocity m/s 
Detonation 
pressure GPa 
Oxygen balance% 
 
TNBI.2H2O 1.789 8295.7 30.8 -22.85 
TNBI:A7 1.709 6681.1 19.3 -106 
TNBI:A12 1.679 6963.4 20.88 -85.86 
TNBI(A14)2 1.819 7924 28.36 -62.4 
TNBI-:A4+ 1.497 6066.3 14.72 -133.28 
RDX 1.816 8753.2 34.6 -21.6 
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 6.3.4 Analysis of the thermal stability 
Thermal stability of TNBI and new solid forms were measured using differential 
scanning calorimetry. Based on the data, the co-crystals of TNBI showed a slight decrease in 
decomposition temperature compared to TNBI. However, all the values were greater than 200oC 
and can be considered as thermally stable (Figure 6-20). 
 
 
 
 
 
 
 
 
 
 
Figure 6-20 Analysis of the decomposition temperature of the TNBI and its co-crystals 
 
  6.3.5 Hygroscopicity test studies 
Even though TNBI is considered as a potential replacement of RDX, its hygroscopic 
nature makes it unsuitable as an explosive. According to TGA data, TNBI shows a loss of 
weight in the range of 80-100 oC (Figure 6-21) and this suggests that water is absorbed through 
acidic hydrogen.7 
 
 
 
TNBI 
TNBI-:A4+ 
TNBI:A12 
TNBI(A14)2 
TNBI:A7 
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Figure 6-21 TGA analysis of TNBI showing a water loss at a region of 80-100oC 
 
We have demonstrated successful replacement of water with different co-formers and the 
acidic N-H protons are no longer available for further reactivity. Analysis of the co-crystals 
through TGA, did not show any weight loss in the 80-100oC range confirming successful 
decrease in hygroscopicity. To further confirm the stability of co-crystals, they were placed in a 
75% humidity chamber for one month and the analysis of TGA showed no difference to the 
initial data, suggesting that hydrogen bond formation between TNBI and co-formers is very 
stable. Figure 6-22 shows TGA analysis of TNBI:(A14)2 which shows a flat region in the 80-
100oC range. 
 
Figure 6-22 TGA analysis of TNBI:(A14)2 which shows a flat region at 80-100oC range 
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 6.3.6 Corrosion test studies 
A small amount of sample was placed on a polished copper strip and a drop of methanol 
was added to aid corrosion. Observation was taken after one hour. Parent TNBI showed high 
corrosion on a copper strip due to the presence of acidic N-H protons (Figure 6-23). All the co-
crystals of TNBI showed successful decrease in corrosion due to the unavailability of acidic 
proton for reactivity, through the formation of hydrogen bonds. Figure 6-24 showed one example 
of successful reduction of corrosion of a co-crystal. 
Initial       After 1 h 
 
 Figure 6-23 Corrosion test studies of TNBI 
 
Figure 6-24 Corrosion test studies of TNBI:A12 
 
 
 6.4 Conclusion 
The energetic material TNBI was successfully synthesized and subjected to co-
crystallization experiments. Crystal data confirmed N-H---N and N-H----O hydrogen bond 
formation with both oxygen and nitrogen based acceptors with the replacement of water 
molecules (Figure 6-25). Hygroscopicity test analysis showed successful decrease in 
hygroscopicity; keeping the solids in a 75% humidity chamber for more than one month 
confirms the stability of new co-crystals. Corrosion studies on a copper strip further confirm the 
chemical inactivity and suggest these materials are safe for long term storage and handling. To 
the best of our knowledge this study is the first attempt taken to reduce hygroscopicity of 
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energetic materials through co-crystallization and can be successfully applied in future in 
designing new energetic materials. 
 
 
 
 
 
 
 
Figure 6-25 Successful reduction of hygroscopicity of TNBI by introducing stable co-
formers 
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Appendix A - 1H NMR, 19F NMR and PXRD data 
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Powder pattern of (A1)2:DOD co-crystal obtained through solvothermal method 
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Stimulated powder pattern of (A1)2:DOD co-crystal analysis 
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 Powder patter of (A1)2:SUB co-crystal obtained through solvothermal method  
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Stimulated powder pattern of (A1)2:SUB  
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Stimulated powder pattern of (A1)2:SUC 
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Powder pattern of (A1)2:SUC obtained through solvothermal method 
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